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Vip Interneuron Cell And Circuit Dysfunction Underlying Dravet Syndrome
Abstract
GABAergic inhibitory interneurons of the cerebral cortex expressing vasoactive intestinal peptide (VIPINs) are rapidly emerging as important regulators of network dynamics and normal circuit development.
Several recent studies have also identified VIP-IN dysfunction in models of genetically determined
neurodevelopmental disorders (NDDs). In this dissertation, we review the known circuit functions of VIPINs and how they may relate to accumulating evidence implicating VIP-IN dysfunction in the mechanisms
of prominent NDDs. We highlight recurring VIP-IN mediated circuit motifs that are shared across cerebral
cortical areas, and how VIP-IN activity can shape sensory input, development, and behavior. Ultimately, we
extract a set of themes that inform our understanding of how VIP-INs influence pathogenesis of NDDs.
We focus on a particularly enticing disease candidate: Dravet Syndrome, a severe NDD characterized by
epilepsy, autism spectrum disorder (ASD), and intellectual disability (ID) caused by loss of function
variants in SCN1A which codes for the voltage-gated Na+ channel α subunit, Nav1.1. We go on to show
that Nav1.1 is expressed in VIP-INs, and loss of a single copy causes VIP-INs to be hypoexcitable in acute
brain slices from Scn1a+/- mice. Using this same model, we show that this intrinsic hypoexcitability
translates to decreased VIP-IN activity and impaired cortical network dynamics in vivo using two-photon
calcium imaging. We find that the above results are replicated when using a conditional deletion of Scn1a
in VIP-INs. However, these conditional mutants do not have epilepsy like the global model, but do
replicate core features of ASD and ID. This dissociates the roles of VIP-IN dysfunction from potential
involvement of other cell types in Dravet pathogenesis. Finally, using publicly available single cell RNA
sequencing (scRNA-seq) data from the Allen Institute, we also identify several underexplored diseaseassociated genes that are highly expressed in VIP-INs. We survey these genes and their shared related
disease phenotypes that may broadly implicate VIP-INs in ASD and ID rather than epilepsy. We conclude
with a discussion of the relevance of cell type-specific investigations to drive the potential development of
therapeutics targeting VIP-INs in the age of genomic diagnosis and precision medicine.
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ABSTRACT

VIP INTERNEURON CELL AND CIRCUIT DYSFUNCTION UNDERLYING DRAVET
SYNDROME
Kevin M. Goff
Ethan M. Goldberg
GABAergic inhibitory interneurons of the cerebral cortex expressing vasoactive intestinal
peptide (VIP-INs) are rapidly emerging as important regulators of network dynamics and
normal circuit development. Several recent studies have also identified VIP-IN
dysfunction in models of genetically determined neurodevelopmental disorders (NDDs).
In this dissertation, we review the known circuit functions of VIP-INs and how they may
relate to accumulating evidence implicating VIP-IN dysfunction in the mechanisms of
prominent NDDs. We highlight recurring VIP-IN mediated circuit motifs that are shared
across cerebral cortical areas, and how VIP-IN activity can shape sensory input,
development, and behavior. Ultimately, we extract a set of themes that inform our
understanding of how VIP-INs influence pathogenesis of NDDs. We focus on a
particularly enticing disease candidate: Dravet Syndrome, a severe NDD characterized
by epilepsy, autism spectrum disorder (ASD), and intellectual disability (ID) caused by
loss of function variants in SCN1A which codes for the voltage-gated Na+ channel α
subunit, Nav1.1. We go on to show that Nav1.1 is expressed in VIP-INs, and loss of a
single copy causes VIP-INs to be hypoexcitable in acute brain slices from Scn1a+/- mice.
Using this same model, we show that this intrinsic hypoexcitability translates to
decreased VIP-IN activity and impaired cortical network dynamics in vivo using twophoton calcium imaging. We find that the above results are replicated when using a
conditional deletion of Scn1a in VIP-INs. However, these conditional mutants do not
v

have epilepsy like the global model, but do replicate core features of ASD and ID. This
dissociates the roles of VIP-IN dysfunction from potential involvement of other cell types
in Dravet pathogenesis. Finally, using publicly available single cell RNA sequencing
(scRNA-seq) data from the Allen Institute, we also identify several underexplored
disease-associated genes that are highly expressed in VIP-INs. We survey these genes
and their shared related disease phenotypes that may broadly implicate VIP-INs in ASD
and ID rather than epilepsy. We conclude with a discussion of the relevance of cell typespecific investigations to drive the potential development of therapeutics targeting VIPINs in the age of genomic diagnosis and precision medicine.

vi

TABLE OF CONTENTS

ACKNOWLEDGMENT ........................................................................................ IV
ABSTRACT .......................................................................................................... V
LIST OF TABLES ............................................................................................... IX
LIST OF ILLUSTRATIONS .................................................................................. X
CHAPTER 1: A ROLE FOR VIP INTERNEURONS IN
NEURODEVELOPMENTAL DISORDERS .......................................................... 1
INTRODUCTION .............................................................................................................................. 1
CIRCUIT FUNCTIONS OF VIP-INS ................................................................................................ 2
VIP-INS SHAPE RESPONSE TO SENSORY INPUTS ................................................................... 5
VIP-INS INFLUENCE ATTENTION AND PERFORMANCE ACROSS MULTIPLE LEARNING
PARADIGMS ................................................................................................................................... 7
VIP-INS ARE REQUIRED FOR NORMAL CIRCUIT DEVELOPMENT .......................................... 8
VIP-IN DYSFUNCTION IS IMPLICATED IN A PROMINENT NDD ................................................ 9
VIP-INS MAY BE INVOLVED IN BROADER NEUROPSYCHIATRIC DISORDERS .................. 10
VIP-IN FUNCTION IN THE CONTEXT OF DRAVET SYNDROME .............................................. 10
REFERENCES ............................................................................................................................... 14

CHAPTER 2: VIP INTERNEURONS ARE IMPAIRED IN A MOUSE MODEL OF
DRAVET SYNDROME ....................................................................................... 25
ABSTRACT ................................................................................................................................... 25
INTRODUCTION ............................................................................................................................ 26
RESULTS ...................................................................................................................................... 29
DISCUSSION ................................................................................................................................. 49
MATERIALS AND METHODS ...................................................................................................... 54
SUPPLEMENTAL FIGURES ......................................................................................................... 72
REFERENCES ............................................................................................................................... 90

vii

CHAPTER 3: VIP INTERNEURON DYSFUNCTION UNDERLIES ABNORMAL
NEOCORTICAL STATE TRANSITIONS AND BEHAVIOR IN A SEVERE
NEURODEVELOPMENTAL DISORDER ........................................................... 98
ABSTRACT ................................................................................................................................... 98
INTRODUCTION .......................................................................................................................... 100
RESULTS .................................................................................................................................... 104
DISCUSSION ............................................................................................................................... 116
MATERIALS AND METHODS .................................................................................................... 121
SUPPLEMENTAL FIGURES ....................................................................................................... 139
REFERENCES ............................................................................................................................. 149

CHAPTER 4: EXPLORING VIP-INS AS A THERAPEUTIC TARGET IN
DRAVET SYNDROME AND BEYOND ............................................................ 159
SEARCHING FOR DISEASE GENES IMPORTANT FOR VIP-IN FUNCTION .......................... 160
POINTS OF CONVERGENCE BETWEEN EXPERIMENTAL MODELS OF ASD ..................... 166
TOWARDS CELL TYPE-SPECIFIC THERAPIES ...................................................................... 169
REFERENCES ............................................................................................................................. 173

viii

LIST OF TABLES

TABLE 2.1. KEY RESOURCES ............................................................................. 54
TABLE 2.2. PROPERTIES OF VIP-INS FROM SCN1A+/- AND WT LITTERMATES ........... 79
TABLE 3.1 KEY RESOURCES

............................................................................... 121

TABLE 3.2. DATA AND NETWORK TRAINING PARAMETERS USED IN DLC POSE
ESTIMATION. ...................................................................................................... 148
TABLE 4.1. CELL TYPE SPECIFIC EXPRESSION OF NDD GENES .............................. 161

ix

LIST OF ILLUSTRATIONS

FIGURE 1.1. CIRCUIT FUNCTIONS OF VIP-INS IN NDDS. ............................................... 4
FIGURE 2.1. VIP-INS EXPRESS NAV1.1 AND ARE HYPOEXCITABLE IN SCN1A+/- MICE

31

FIGURE 2.2. TWO VIP-IN FIRING PATTERNS REVEALED WITH LONG DEPOLARIZATION 34
FIGURE 2.3. IS VIP-INS ARE PREFERENTIALLY IMPAIRED IN SCN1A+/- MICE ............. 35
FIGURE 2.4. HM1A APPLICATION MODULATES NA+ CHANNELS CONTAINING NAV1.1
SUBUNITS IN VIP-INS AND RECOVERS IS VIP-IN HYPOFUNCTION IN SCN1A+/- MICE .. 39
FIGURE 2.5. INTERSECTIONAL EXPRESSION OF CR AND CCK LABELS ANATOMICAL
SUBSETS OF VIP-INS BUT DOES NOT CORRELATE WITH IS VS. CA FIRING PATTERNS.

........................................................................................................................... 42
FIGURE 2.6. KCNQ CHANNELS REGULATE VIP-IN FIRING PATTERNS ......................... 43
FIGURE 2.7. CHOLINERGIC MODULATION INDUCES SWITCHING FROM IRREGULAR TO
CONTINUOUS FIRING IN IS VIP-INS ......................................................................... 45
FIGURE 2.8. SINGLE COMPARTMENT MODEL OF A VIP-IN ILLUSTRATES THE
INTERACTION BETWEEN M-CURRENT AND NA+ CURRENT ...................................... 48
FIGURE 2.S1. SCN1A EXPRESSION IN VIP-INS .......................................................... 72
FIGURE 2.S2. LOCALIZATION OF NAV1.1 ON VIP-IN AXONS. ...................................... 73
FIGURE 2.S4. IS VIP-IN FIRING PATTERNS ARE ROBUST TO A VARIETY OF STIMULATION
METHODS ............................................................................................................ 76
FIGURE 2.S5. A SUBSET OF BOTH CA AND IS VIP-INS SHOW BURSTING AT RHEOBASE

........................................................................................................................... 78
FIGURE 2.S6. IS VIP-IN DEFICITS IN SCN1A+/- MICE ARE CONSISTENT ACROSS
DEVELOPMENT. .................................................................................................... 80

x

FIGURE 2.S7. IS VIP-IN DEFICITS IN SCN1A+/- MICE ARE CONSISTENT ACROSS
CORTICAL AREAS ................................................................................................. 82
FIGURE 2.S8. EFFECTS OF LOW CONCENTRATION HM1A ON IS VIP-IN FIRING ............ 83
FIGURE 2.S9. KCNQ5 IS SELECTIVELY EXPRESSED IN A SUBSET OF VIP-INS ............. 84
FIGURE 2.S10. KCNQ5 BUT NOT KCNQ3 IS EXPRESSED IN VIP-INS ............................ 86
FIGURE 2.S11. LINOPIRDINE HAS NO EFFECT ON CA VIP-IN EXCITABILITY ................. 87
FIGURE 2.S12. MUSCARINIC BUT NOT NICOTINIC RECEPTOR ACTIVATION IS
SUFFICIENT TO INDUCE IRREGULAR-TONIC SWITCHING IN IS VIP-INS ....................... 88
FIGURE 3.1. ALTERED IN VIVO VIP-IN ACTIVITY AND CSTS IN SCN1A+/- MICE. ......... 105
FIGURE 3.2. EFFECT OF CHOLINERGIC MODULATION ON VIP-IN CELLULAR
EXCITABILITY AND SODIUM CURRENT. ................................................................. 107
FIGURE 3.3. OPTOGENETIC ACTIVATION OF VIP-INS DURING LOCOMOTION BOUTS
RESTORES ASPECTS OF NORMAL CORTICAL DYNAMICS IN SCN1A+/- MICE.................. 107
FIGURE 3.4. VIP-IN SPECIFIC LOSS OF SCN1A RECAPITULATES THE CELLULAR
DEFICITS OBSERVED IN VIP-INS IN GLOBAL SCN1A+/- MICE .................................. 111
FIGURE 3.5. LOSS OF SCN1A IN VIP-INS PRODUCES CIRCUIT DEFICITS IN VIVO THAT
ARE EXACERBATED BY MUSCARINIC ACTIVATION. ............................................... 113
FIGURE 3.6. LOSS OF SCN1A IN VIP-INS REPLICATES CORE COGNITIVE IMPAIRMENTS
AND ASD ENDOPHENOTYPES OF THE GLOBAL SCN1A+/- DS MODEL. .................... 115
FIGURE 3.S1: MARKERS OF BEHAVIORAL STATE CHANGES ARE CONSISTENT ACROSS
GENOTYPES DURING 2P IMAGING SESSIONS. ....................................................... 139
FIGURE 3.S2: NEUROPIL BACKGROUND FLUORESCENCE CORRECTION. ................ 140
FIGURE 3.S3: ISOLATING DEFINITIVE PYRAMIDAL NEURONS FROM TDT- NON-VIP
NEURONS. .......................................................................................................... 141
FIGURE 3.S4: VIP-IN TO NETWORK CORRELATION IS REDUCED IN SCN1A+/- MICE. . 143

xi

FIGURE 3.S5: EVENT DECONVOLUTION FROM DF/F0. ............................................. 144
FIGURE 3.S6: CARBACHOL HAS A SIMILAR EFFECT ON VIP-INS WITH DIFFERING FIRING
PATTERNS.......................................................................................................... 145
FIGURE 3.S7: DIVERSE NETWORK RESPONSES IN RESPONSE TO OPTOGENETICALLY
STIMULATION OF VIP-INS. .................................................................................... 146
FIGURE 3.S8: COMPARISON OF DLC BASED PROXIMITY SCORING AND BLINDED
MANUAL SCORING OF NOR INTERACTIONS. ......................................................... 147
FIGURE 4.1. RELATIVE EXPRESSION OF NDD RELATED DISEASE GENES IN VIP-INS . 164
FIGURE 4.2. SEPARATION OF IN SUBCLASSES BASED ON NDD DIAGNOSTIC PANEL
GENES ............................................................................................................... 169

xii

CHAPTER 1: A Role for VIP Interneurons in Neurodevelopmental
Disorders
Introduction
While comprising only a fraction of the total cells in the cerebral cortex,
interneurons (INs) have garnered significant attention due to their complex and dynamic
roles in shaping network activity and behavior. Furthermore, many neurological
disorders may involve impaired IN function (Hattori et al., 2017). IN dysfunction is often
framed in the context of excitation/inhibition (E/I) imbalance, a useful simplification.
However, INs are embedded within myriad complex repeating circuit motifs in the
cerebral cortex, including feedforward, feedback, and disinhibitory interconnectivity
(Kepecs and Fishell, 2014). As a result, the three largest subclasses of INs, which
express parvalbumin, somatostatin, or vasoactive intestinal peptide (PV, SST, and VIPINs) (Rudy et al., 2011), take part in diverse circuit functions, from regulation of
neuromodulatory influences on neocortex to spike timing and synchronization. INs also
serve as mediators of normal circuit development by regulating critical period plasticity
and shaping the formation of sensory maps (Hattori et al., 2017). There is strong interest
in identifying the role of IN subclasses in genetically determined neurodevelopmental
disorders (NDDs). VIP-INs in particular have unique circuit functions which position them
as a potentially important locus of pathology in NDDs. While we have a blossoming
understanding of how VIP-INs influence normal cortical circuit activity and development,
the contributions of VIP-INs to specific NDDs are just beginning to be explored.
Here, we examine the circuit impact of VIP-INs, extracting recurrent themes to
suggest how VIP-IN dysfunction might contribute to NDDs (Fig. 1). We summarize early
evidence for VIP-IN involvement in Dravet syndrome (DS), a severe NDD caused by
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loss of function mutations in SCN1A, and more broadly across epilepsy and autism
spectrum disorder (ASD). We then present original research demonstrating that VIP-IN
excitability depends upon expression of the voltage-gated sodium (Na+) channel subunit
Nav1.1, which is coded by Scn1a, and that VIP-INs are dysfunctional in a mouse model
of DS with heterozygous loss of Scn1a. This dysfunction causes abnormal activity in the
neocortex and underlies ASD related endophenotypes in this model. Finally, using single
cell RNA sequencing (scRNA-seq) data available from the Allen Institute (Yao et al.,
2021), we highlight several prominent disease genes that are highly expressed in VIPINs. Thus, we explore avenues for better understanding VIP-IN function while also
implicating VIP-IN dysfunction in NDD pathogenesis and more broadly in ASD. We
conclude by discussing how cell-type specific manipulations targeted at VIP-INs may
drive the development of novel therapeutic approaches.

Circuit functions of VIP-INs
The existence of VIP-expressing as well as IN-targeting cells in neocortex and
hippocampus has been known for 30-40 years (Acsády et al., 1996; Dávid et al., 2007;
Hájos et al., 1996; Porter et al., 1998, 1999). Comprising only 10% of cerebral cortex INs
(Rudy et al., 2011), understanding of VIP-IN function has been accelerated by the
availability of genetic tools to target discrete IN subpopulations (Dimidschstein et al.,
2016; He et al., 2016; Taniguchi et al., 2011). Although it is the case that all INs target
other INs to some extent, several studies using VIP-Cre mice to record, image, and
manipulate VIP-INs indicate that they preferentially inhibit other INs, increase activity of
local pyramidal neurons, and are functionally disinhibitory (Fu et al., 2014; Lee et al.,
2013; Pfeffer et al., 2013; Pi et al., 2013). Nevertheless, VIP-INs do form direct inhibitory
synapses onto local pyramidal neurons, although the functional significance of these
2

direct connections is not well understood (Zhou et al., 2017). There is considerable
heterogeneity within VIP-INs including non-overlapping populations marked by the
expression of cholecystokinin and calretinin, as well as a subset of VIP-INs that
corelease acetylcholine (Gouwens et al., 2019, 2020; Granger et al., 2020; He et al.,
2016; Obermayer et al., 2019; Paul et al., 2017; Prönneke et al., 2015; Tasic et al.,
2016). There is some evidence that VIP itself can shape cerebral blood flow and
neuronal excitability, but this has not been specifically tied to VIP-IN activity (Cunha-Reis
and Caulino-Rocha, 2020; Cunha-Reis et al., 2005; Yang et al., 2010). It remains largely
unknown how this within-type diversity relates to VIP-IN circuit function.

Despite unresolved aspects of diversity within the VIP-IN subclass, there remain
several core features of circuits containing VIP-INs that are remarkably well conserved
across brain regions (Guet-McCreight et al., 2020) . For example, VIP-INs are uniformly
recruited by cholinergic neuromodulation (Askew et al., 2019; Fu et al., 2014; Porter et
al., 1999; Prönneke et al., 2020; Reimer et al., 2014), and preferentially target SST-INs
(Fu et al., 2014; Krabbe et al., 2019; Lee et al., 2013; Muñoz et al., 2017; Pfeffer et al.,
2013; Tyan et al., 2014; Walker et al., 2016). Taken together, this means that VIP-INs
disinhibit the dendrite-targeted GABAergic input provided by SST-INs in brain states
characterized by increased cholinergic tone. These occur during active behaviors like
running and whisking in rodents, and are also marked by enhanced hippocampal theta
rhythm (Fu et al., 2014; Gasselin et al., 2021; Jackson et al., 2016; Khan et al., 2018;
Luo et al., 2020; McGinley et al., 2015; Reimer et al., 2014; Turi et al., 2019). VIP-INs
express nicotinic (Askew et al., 2019; Paul et al., 2017; Porter et al., 1999; Tasic et al.,
2016) and muscarinic (Goff and Goldberg, 2019) acetylcholine receptors, as well as
receptors for other neuromodulators including the ionotropic serotonin receptor 5-HT3R
3

(Lee et al., 2010; Prönneke et al., 2020). Beyond direct depolarization by acetylcholine,
a diverse repertoire of metabotropic receptors shapes the intrinsic excitability of VIP-INs
through regulating ionic conductances such as M-type potassium current (Goff and
Goldberg, 2019) and T-type calcium current (Prönneke et al., 2020). VIP-INs also
integrate long-range cortico-cortical input (Lee et al., 2013; Zhang et al., 2014). Overall,
this positions VIP-INs as a key component of top-down neuromodulation in the
neocortex, defining the cellular and circuit basis for how VIP-INs shape cortical
processing.

Figure 1. Circuit Functions of VIP-INs in NDDs. Diagrammatic representation of VIPIN regulated circuits and their impact on biology and disease. VIP-INs are components
4

of several repetitive circuit motifs in the cerebral cortex, including a prominent
disinhibitory circuit that is conserved across many brain areas. The activity of VIP-INs
not only influences network dynamics, but also the development of normal neural
circuits. This shapes behaviours in several important ways, including learning, memory,
and attention. Finally, impaired VIP-IN function caused by mutations in certain disease
genes may cause abnormal circuit function and behaviour that underlies NDD
endophenotypes like autism spectrum disorder (ASD), intellectual disability (ID), and
developmental delay (DD). Figure created with BioRender.com.

VIP-INs shape response to sensory inputs
VIP-INs play a particularly important role in shaping neocortical response to
sensory inputs. The canonical VIP-IN disinhibitory circuit is found in essentially all
primary sensory areas in rodents. In visual cortex (V1), VIP-IN recruitment during active
behaviors increases the gain of layer 2/3 pyramidal neurons without affecting their
orientation selectivity (Fu et al., 2014; Reimer et al., 2014). Correspondingly, optogenetic
stimulation of VIP-INs during a visual contrast detection task improves performance,
while coactivating either SST or PV-INs reduces the ability of the mouse to detect lower
contrasts (Cone et al., 2019). Long range projections from the cingulate cortex activate
this circuit, providing another mechanism for top down modulation of early visual
processing analogous to the frontal eye fields in primates (Zhang et al., 2014). This
pathway drives narrow bands of disinhibition within visual columns and enhances both
visual responses and performance on a discrimination task.

VIP-INs in auditory cortex (A1) are strongly activated by cholinergic stimulation
(Askew et al., 2019), but the exact relationship between locomotion and VIP-INmediated disinhibition may be different than in V1 (Bigelow et al., 2019). Nevertheless,
direct VIP-IN activation disinhibits a subset of tone-responsive neurons, resulting in an
increase in the gain of the corresponding tuning curves (Pi et al., 2013). Cortico-cortical
5

motor signals arising from whisking act in parallel to ascending cholinergic
neuromodulation to drive VIP-IN activity in barrel cortex (S1) (Lee et al., 2013).
Interestingly, whisking causes inhibition of a subset of Martinotti-type SST-INs via VIPINs, yet other SST-INs are actually recruited by muscarinic acetylcholine receptor
activation (Muñoz et al., 2017). VIP-INs are clearly able to increase the gain of sensory
responses in primary sensory areas, but there may be meaningful region-specific
differences in what is otherwise a highly conserved circuit motif.

While top-down disinhibition through VIP-INs enhances the gain of sensory
signals on a trial-by-trial basis, VIP-INs also promote plasticity and themselves exhibit
plastic responses, which could influence developmental processes. Indeed, theoretical
work suggests that disinhibition may be a mechanism for associative learning in the
neocortex (Wilmes and Clopath, 2019). Supporting this hypothesis, inactivation, or
activation, of VIP-INs in V1 can impair or enhance plasticity after monocular deprivation,
respectively (Fu et al., 2015). While the response of V1 VIP-INs to simple visual stimuli
like drifting gratings is variable (Millman et al., 2020; de Vries et al., 2020), VIP-INs are
suppressed by familiar natural images but strongly activated by novel images during a
discrimination task (Garrett et al., 2020). Moreover, VIP-INs show strong ramping activity
during the omission of familiar images in the same task, suggesting that VIP-IN activity
may enhance the cortical representation of salient sensory events such as the
presentation of novel stimuli or the absence of expected stimuli. In A1, VIP-INs are
recruited by signals reinforcing both reward and avoidance (Pi et al., 2013), further
suggesting that VIP-INs are involved in encoding the salience of input features across
sensory neocortex.
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VIP-INs influence attention and performance across multiple learning
paradigms
In addition to shaping sensory processing, VIP-INs influence learning, attention,
and plasticity in distributed brain regions. VIP-INs in the basolateral amygdala (BLA) are
recruited by aversive foot shocks in a fear conditioning paradigm, and VIP-IN activity is
enhanced when the shock is unexpected, or is stronger than expected (Krabbe et al.,
2019). Furthermore, blocking VIP-IN activity during the unconditioned foot shock
stimulus reduces projection neuron activity and prevents normal fear conditioning. In
area CA1 of the hippocampus, VIP-INs are also modulated by locomotion (Luo et al.,
2020; Turi et al., 2019), but respond strongly to rewards during spatial learning tasks
(Turi et al., 2019). Blocking VIP-IN activity abolishes the remapping of place cells in CA1
around the location of a rewarding stimulus and negatively impacts the performance of
mice learning the task, while direct activation of VIP-INs concurrent with the reward
improves performance.

Finally, direct activation of VIP-INs in the prefrontal cortex (PFC) improves
performance on a delayed forced choice task, but activation of PV, SST, or pyramidal
neurons during the task all impairs performance (Kamigaki and Dan, 2017). Some VIPINs also show ramping activity during the delay between the cue and test response, and
their ability to increase both correct hits and correct rejections supports the conclusion
that VIP-IN activation improves attention to stimulus presentation during this working
memory task. Similarly, VIP-INs in the PFC are recruited when a mouse is in the open
arm of an elevated plus maze, and inhibiting VIP-IN activity increases exploration of the
open arm (Lee et al., 2019). Thus, VIP-INs in PFC, amygdala, and hippocampus
7

contribute to distinct learning modalities and respond to a variety of salient signals of
both positive and negative valence.

VIP-INs are required for normal circuit development
Overall, VIP-INs have emerged as important components of the cortical circuits
underlying attention and arousal, particularly by attaching salience to features of sensory
input. Through these functions, VIP-IN activity also has a profound impact on multiple
mechanisms of cortical plasticity and forms of learning. The work described above
defines roles for VIP-INs in cerebral cortical circuit operations, but it is now known that
proper VIP-IN function is also required for normal development of these same circuits.
Conditional VIP-IN deletion of ErBb4, a receptor important for normal migration and
synapse formation, results in profound network abnormalities in V1 (Batista-Brito et al.,
2017). This includes disruption of VIP-IN functions such as state transitions and gain
modulation during locomotion, but this perturbation also affects basic network features
including LFP-spike phase locking and orientation selectivity of layer II/III pyramidal
neurons in V1. Interestingly, pyramidal neuron visual responses in the conditional ErBb4
knockout mice closely resemble WT responses at post-natal day (P) 15-18, but these
responses progressively degrade as the mice age, further supporting a dynamic
intersection between VIP-IN function in established circuits and influence over
developmental processes. Critically, these circuit-level deficits cause impaired
performance during a contrast discrimination task, suggesting that VIP-IN dysfunction
gives rise to pathological brain-state regulation that may lead to abnormal behavior.

8

VIP-IN dysfunction is implicated in a prominent NDD
Many NDDs are characterized by behavioral abnormalities and network activity
akin to features that we now know rely on VIP-IN activity. This positions VIP-INs as a
potentially critical yet nearly unexplored cellular locus of circuit dysfunction in NDDs.
Mouse models of prominent human NDDs combined with genetic targeting of VIP-INs
are now being used to investigate the role of VIP-INs in disease. Rett syndrome is a
early-onset NDD characterized by seizures, intellectual disability (ID), features of ASD,
and repetitive stereotypical hand movements (Chahrour and Zoghbi, 2007; Hagberg et
al., 1983). Most cases are found in girls and are caused by missense variants or
deletions in the gene encoding methyl-CpG binding protein 2 (MECP2) located on the X
chromosome. Hemizygous male mice lacking a copy of Mecp2 show many features
consistent with Rett syndrome (Chen et al., 2001; Guy et al., 2001), and, while Mecp2 is
expressed in essentially all neurons, conditional deletion of Mecp2 in cerebral-cortical
INs replicates many of the core features of the global model (Mossner et al., 2020).
Interestingly, mice also show electrophysiological and behavioral deficits when deletion
of Mecp2 is further restricted to VIP-INs (Mossner et al., 2020). In particular, cortical
state transitions at the onset of locomotion are diminished, and, while there is no
increase in seizures or mortality, the mice show abnormal patterns of social behavior
including a failure to display preference for a novel mouse versus an empty chamber.
This phenotype is characteristic of many mouse models of ASD (Antoine et al., 2019;
Tatsukawa et al., 2018), and it is notable that the features of ASD can be dissociated
from the seizure phenotype in this Rett model by selective manipulation of VIP-INs. PV
or SST-IN specific deletions of Mecp2 did not cause the same social deficits. Therefore,
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the primarily disinhibitory role of VIP-INs may underlie some aspects of ASD and/or ID in
Rett syndrome without influencing seizure susceptibility.

VIP-INs may be involved in broader neuropsychiatric disorders
Rett syndrome is an interesting early example of VIP-IN dysfunction in NDDs.
However, there is increasing consensus that many neuropsychiatric disorders have
‘developmental’ origins, including prominent clinical entities like major depression,
bipolar disorder, schizophrenia, and substance abuse/addiction (Owen and O’Donovan,
2017). In mice, expression of an α5 nicotinic receptor (CHRNA5) human variant
associated with nicotine abuse drastically decreases spontaneous VIP-IN activity in vivo
with a corresponding increase in SST-IN activity (Koukouli et al., 2017). This also causes
decreased PFC network activity, and thus may underlie the hypofrontality seen in
patients with this gene variant. Interestingly, Chrna5 variant mice also have social
deficits – a recurring theme in all three of the above examples. At a mechanistic level,
some VIP-INs in the anterior cingulate cortex respond directly to social stimuli (Johnson
et al., 2020), but it remains unknown how VIP-INs influence social behavior. This
represents exciting new territory for basic research into VIP-IN function. The themes
shared between the above results compared to the Rett syndrome model point to a
broader role for VIP-INs in NDDs, with particular reference to features of ASD and ID.

VIP-IN function in the context of Dravet Syndrome
One of the most prominent NDDs that shares features with the diseases and
models mentioned above is Dravet Syndrome (DS), a severe NDD that is characterized
by treatment-resistant epilepsy, ASD, moderate to severe ID, and a high risk of sudden
unexpected death (SUDEP) (Dravet, 2011; Li et al., 2011; Villas et al., 2017). DS is
10

caused by pathogenic heterozygous loss of function variants in SCN1A (Claes et al.,
2001), the gene encoding the voltage-gated sodium (Na+) channel  subunit Nav1.1.
Initially, this presented a paradoxical genetic locus for DS: How does a decrease in
expression of voltage-gated Na+ channels, which drive the intrinsic excitability of
neurons, lead to hyperexcitability and epilepsy? Data from human stem cell derived
neurons, as well as the development of an Scn1a+/- mouse model helped identify that
Nav1.1 is expressed in nearly all INs and is an important determinant of intrinsic
excitability of these cells (Ogiwara et al., 2007; Sun et al., 2016; Tai et al., 2014). This
led to the ‘interneuron hypothesis’ of DS, positing that INs are selectively impaired while
glutamatergic principal neuron function is spared, which alters the excitatory/inhibitory
(E/I) balance and is epileptogenic. While there is some evidence for small subsets of
glutamatergic neurons expressing Nav1.1, both the global Scn1a+/- model and IN specific
deletion replicate core features of the human disease (Cheah et al., 2012; Oakley et al.,
2009; Richards et al., 2018; Rubinstein et al., 2015), while deletion of Scn1a from
telencephalic glutamatergic neurons appears to protect against epilepsy (Ogiwara et al.,
2013). However, the cellular and circuit bases of DS remains unknown and existing
knowledge has yet to lead to cure or disease-modifying treatments. To this end, recent
work has focused on the role of particular IN subclasses in this severe disease.

PV, and SST-INs from multiple cortical regions exhibit impaired action potential
generation and repetitive firing in Scn1a+/- mice, although these abnormalities display
different developmental time courses (Almog et al., 2021; Favero et al., 2018; Goff and
Goldberg, 2019; Rubinstein et al., 2015; De Stasi et al., 2016; Tai et al., 2014). For
instance, neocortical PV-INs are most dysfunctional around P16-P21, corresponding to
11

the onset of Nav1.1 expression when the mice are most prone to seizures and SUDEP,
but regain normal excitability by young adulthood (P50+) (Favero et al., 2018; Kaneko et
al., 2021). CA1 horizontal stratum-oriens INs (most likely expressing SST) also show a
narrow window of severe impairment around P21-24 and partially regain their function in
adult mice (Almog et al., 2021). While it is not clear how and why some IN
subpopulations recover function in Scn1a+/- mice – perhaps through homeostatic
upregulation of other Nav1.X channel subunits – there remains an interesting correlation
between cellular function and DS seizure and behavior phenotypes. Scn1a+/- mice that
survive past an early developmental window tend to have a much lower rate of
spontaneous seizures and death. However, they continue to demonstrate abnormal
behaviors consistent with ASD and ID. Overall, these findings closely mirror what is
known about the human disease: seizure frequency typically decreases with age yet ID
and ASD are durable and longstanding (Genton et al., 2011). Interestingly, some of
these behaviors like sociability and fear conditioned memory are reversibly rescued by
low dose GABA agonists during adulthood in Scn1a+/- mice (Han et al., 2012). This
suggests that IN dysfunction remains in adult Scn1a+/- mice, necessitating the
investigation of other IN subtypes like VIP-INs.
While VIP-INs were initially thought to only express Nav1.2 (Yamagata et al.,
2017), Nav1.1 is expressed at the mRNA level (Goff and Goldberg, 2019; Gouwens et
al., 2018; Yao et al., 2021). Additionally, given their role in plasticity, spatial memory,
stimulus processing, and sociability, we hypothesize that VIP-IN dysfunction may be
involved in the ASD and ID phenotypes of DS. In this series of work, we set out to
investigate the role of VIP-INs in DS by answering the following questions: 1) How is the
intrinsic excitability of VIP-INs affected by the loss of Nav1.1? 2) Does this translate to in
vivo disinhibitory circuit disfunction? 3) Are the ASD related behaviours found in DS
12

models caused by VIP-IN specific dysfunction? Ultimately, the goal of this work is to
identify VIP-INs as a novel disease locus in DS, and if they represent a potential
therapeutic target for ameliorating the core ASD-related aspects of this disease.
Additionally, we explore the shared characteristics between DS and other NDDs to form
a structured outlook on how VIP-INs may impact ASD, while other IN populations may
underlie epilepsy.
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Chapter 2: VIP interneurons are impaired in a mouse model of
Dravet Syndrome

ABSTRACT
Dravet Syndrome (DS) is a severe neurodevelopmental disorder caused by pathogenic
loss of function variants in the gene SCN1A which encodes the voltage-gated sodium
(Na+) channel subunit Nav1.1. GABAergic interneurons expressing parvalbumin (PVINs) and somatostatin (SST-INs) exhibit impaired excitability in DS (Scn1a+/-) mice.
However, the function of a third major class of interneurons in DS – those expressing
vasoactive intestinal peptide (VIP-IN) –is unknown. We recorded VIP-INs in brain slices
from Scn1a+/- mice and wild-type littermate controls and found prominent impairment of
irregular spiking (IS), but not continuous adapting (CA) VIP-INs, in Scn1a+/- mice.
Application of the Nav1.1-specific toxin Hm1a rescued the observed deficits. The IS vs.
CA firing pattern is determined by expression of KCNQ channels; IS VIP-INs switched to
tonic firing with both pharmacologic blockade of M-current and muscarinic acetylcholine
receptor activation. These results show that VIP-INs express Nav1.1 and are
dysfunctional in DS, which may contribute to DS pathogenesis.
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INTRODUCTION
Dravet syndrome (DS) is a severe neurodevelopmental disorder characterized by
temperature-sensitive and spontaneous seizures in the first year of life followed by
progression to intractable epilepsy, intellectual disability with autistic features, and a
markedly increased rate of sudden unexpected death (SUDEP) (Genton et al., 2011;
Kalume et al., 2013; Oakley et al., 2009; Scheffer, 2012). DS is caused by pathogenic
loss of function variants in the gene SCN1A, resulting in haploinsufficiency of the
voltage-gated sodium (Na+) channel α subunit Nav1.1 (Claes et al., 2001). Experimental
models of DS, including mice lacking a functional copy of Nav1.1 (Scn1a+/- mice) (Mistry
et al., 2014; Ogiwara et al., 2007; Yu et al., 2006) and neurons generated from induced
pluripotent stem (iPS) cells derived from DS patients (Liu et al., 2013; Sun et al., 2016),
have provided important insights into the cellular and circuit basis of this disorder.
Parvalbumin-immunopositive fast-spiking GABAergic interneurons (PV-INs) and
somatostatin (SST)-expressing dendrite-targeting INs (SST-INs) exhibit impaired
excitability in Scn1a+/- mice (Favero et al., 2018; Ogiwara et al., 2007; De Stasi et al.,
2016; Tai et al., 2014; Yu et al., 2006). Despite advances in the understanding of
underlying disease pathogenesis, DS remains incurable with a poor prognosis. How loss
of Nav1.1 leads to the features that define this clinical syndrome is incompletely
understood, and identifying new, targetable loci of dysfunction is critically important to
developing new treatments.

Nav1.1 is expressed at the axon initial segment (AIS) of PV-INs and, to a lesser
extent, SST-INs, and is a major determinant of action potential (AP) generation in these
cells (Li et al., 2014; Ogiwara et al., 2007; De Stasi et al., 2016; Tai et al., 2014). Such
data have led to the “interneuron hypothesis” of DS, which posits that PV and SST-IN
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dysfunction is the predominant driver of both epilepsy and autism (Catterall, 2018;
Catterall et al., 2010; Han et al., 2012; Ogiwara et al., 2007; Rubinstein et al., 2015; Yu
et al., 2006). However, we recently showed that PV-IN hypoexcitability in Scn1a+/- mice
is restricted to an early and transient developmental window (P11-21), with subsequent
normalization of high-frequency action potential discharge by P35 (Favero et al., 2018).
This finding encourages a reconsideration of the cellular basis of circuit pathology that
underlies chronic epilepsy and epilepsy-associated cognitive abnormalities in DS. The
functional status of the rich diversity of interneurons in the cerebral cortex (DeFelipe et
al., 2013; Tremblay et al., 2016) has not been fully explored in models of DS. It could be
the case that other interneuron classes are also affected and exhibit chronic dysfunction.
The impact of constitutive loss of Nav1.1 on the third major class of cortical INs – those
expressing vasoactive intestinal peptide (VIP-INs) – remains unknown.

VIP-INs are functionally distinct from SST and PV-INs as they preferentially
target other interneurons (particularly SST-INs) rather than pyramidal cells, and thus are
considered to exert a disinhibitory influence on cerebral cortical circuits (Acsády et al.,
1998; Fu et al., 2014; Krabbe et al., 2018; Lee et al., 2013; Munoz et al., 2017; Pi et al.,
2013; Turi et al., 2019; Zhang et al., 2014). VIP-INs also have a role in regulating the
response of the cerebral cortex to ascending cholinergic neuromodulatory input from the
basal forebrain (Alitto and Dan, 2013; Fu et al., 2015; Kawaguchi, 1997; Porter et al.,
1999), and hence are involved in higher-order functions such as attention, memory, and
cognitive processing, all of which are impaired in DS (Dravet and Oguni, 2013). Prior
work has suggested that VIP-INs do not express Nav1.1 (Yamagata et al., 2017), while
recent single cell RNA sequencing studies do suggest expression of Nav1.1 in VIP-INs
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(Paul et al., 2017; Tasic et al., 2016). Here, we assessed the functional status of VIP-INs
in Scn1a+/- mice and directly investigated whether VIP-INs express Nav1.1.

To address this question, we performed targeted whole cell recordings from layer
2/3 VIP-INs in acute brain slices of primary somatosensory and visual cortex in male and
female Scn1a+/- mice and age-matched wild-type (WT) littermate controls at two different
developmental time points. We found that VIP-INs exhibit impairment of AP generation
and repetitive firing and confirmed the presence of Nav1.1 on putative VIP-IN axons
using immunohistochemistry and confocal microscopy. However, unlike the transient
abnormalities seen in PV-INs (Favero et al., 2018), this VIP-IN deficit persisted at later
developmental time points. We further found that VIP-IN dysfunction in Scn1a+/- mice
was restricted to a subset of irregular spiking (IS) VIP-INs, while continuous adapting
(CA) VIP-INs were essentially normal. Deficits seen in IS VIP-INs could be reversed by
application of the peptide toxin Hm1a, a recently-identified Nav1.1-specific modulator
(Osteen et al., 2016). The basis of the IS firing pattern involved M-current mediated by
KCNQ channels likely containing Kcnq5. Blockade of M-current with the KCNQ channel
inhibitor linopirdine converted IS VIP-INs to a tonic firing mode but had no effect on CA
VIP-INs. Also, muscarinic, but not nicotinic cholinergic receptor activation reversibly
converted IS VIP-INs to a continuous firing mode. Overall, these results identify a novel
cellular locus of dysfunction in DS that may relate to the profound and durable cognitive
impairments observed in human patients (Genton et al., 2011; Scheffer, 2012; Villas et
al., 2017) and additionally refines our understanding of the diversity of VIP-INs and the
molecular determinants of VIP-IN function.
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RESULTS
Neocortical vasoactive intestinal peptide expressing interneurons exhibit impaired
excitability in Scn1a+/- mice
To assess the function of neocortical VIP-INs in Scn1a+/- mice, we performed
targeted whole cell patch clamp recordings from fluorescently labeled neurons in layer
2/3 of primary somatosensory (“barrel”) cortex in acute brain slices prepared from
juvenile and young adult triple transgenic Scn1a.VIP-Cre.tdTomato (tdT) mice and agematched WT.VIP-Cre.tdT littermate controls (see Materials and Methods). VIP-INs from
Scn1a+/- mice demonstrated multiple abnormalities that were consistent with loss of Na+
current (Figure 1), including a reduced maximal steady-state firing frequency (67 ± 2 vs.
48 ± 3 Hz; p = 3 X E-6; n = 150/123 WT/Scn1a+/-), as well as a marked shift in the
current/frequency (I/f; input-output) curve. There was notable spike height
accommodation (rundown) during repetitive action potential discharge with a progressive
depolarization of AP threshold and a decrease in AP peak value during suprathreshold
current injections, suggesting enhanced accumulation of Na+ channel inactivation in VIPINs from Scn1a+/- mice. This data supports the conclusion that neocortical VIP-INs are
hypoexcitable in Scn1a+/- mice relative to age-matched WT littermate controls, likely due
to absence of one copy of Scn1a and a resulting decrease in Na+ current.

VIP interneurons express Nav1.1
Nav1.1 is known to be expressed in PV-INs and SST-INs, while a recent study
suggested that VIP-INs express Nav1.2 at higher levels (Yamagata et al., 2017).
However, several recent large-scale transcriptomics datasets suggest that Scn1a mRNA
is in fact expressed in VIP-INs, and at levels similar to that seen in SST-INs (Figure S1)
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(Paul et al., 2017; Tasic et al., 2016). We performed immunohistochemical analysis to
confirm the presence of Nav1.1 protein in VIP-INs.
We identified fine (0.5 µm) tdT positive, Nav1.1-immunoreactive processes
emanating from the soma (Figure 1Ei-ii) or proximal dendrite (Figure 1Eiii-iv) of labeled
neurons in WT.VIP-Cre.tdT mice; these were considered to correspond to the VIP-IN
axon based on small caliber and larger branching angle (Prönneke et al., 2015). We
identified the axon in 30 VIP-INs and found that 23 of 30 (77%) identified axons
expressed Nav1.1 (Figure S2). In order to validate the specificity of this staining, we
performed Nav1.1 immunohistochemistry of tissue from Scn1a-/- null mice and found no
immunoreactivity (Figure S3 A-B). As a positive control, we found high expression of
Nav1.1 on PV-IN axons (Figure S3 C). This data confirms that Nav1.1 protein is present
on the axon of many VIP-INs.
Two electrophysiological subgroups of VIP-INs in neocortical layer 2/3
Results presented thus far indicate that VIP-INs express Nav1.1 and exhibit
impaired excitability in Scn1a+/- mice. In the course of these initial experiments, we
observed a subset (~50%) of VIP-INs in Scn1a+/- mice that only fired a brief train of APs
before complete cessation of firing (Figure 1A), which was atypical for VIP-INs from WT
mice. This prompted us to explore how our data from Scn1a+/- mice mapped onto
previously described VIP-IN firing patterns. VIP-INs in superficial layers of mouse and rat
barrel cortex exhibit spike frequency adaptation with or without irregular spiking and/or
initial bursting (variably referred to in the literature as continuous adapting, irregular
spiking, bursting, or fast adapting) (He et al., 2016; Prönneke et al., 2015). However,
there is no existing standardized or widely agreed upon nomenclature to describe VIP-IN
firing patterns.
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Figure 1. VIP-INs express Nav1.1 and are hypoexcitable in Scn1a+/- mice
A) Representative traces of layer 2/3 VIP-INs from a Scn1a+/- mouse and age matched
WT littermate. Location of scale bar indicates -70 mV. Black indicates rheobase
current injection, while gray indicates response to a -50 pA hyperpolarizing and a 2X
rheobase suprathreshold current injection.
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B) Current/frequency (I-f) output curve of n = 123 VIP-INs from 24 Scn1a+/- mice and n
= 150 VIP-INs from 38 age matched WT littermates (See Figure S6 for age specific
data). Line and shaded area represent mean +/- SEM, and the black bar indicates
significance at p < 0.01 by a multivariate ANOVA and post-hoc Bonferroni correction.
C) Population average of spike amplitude (AP peak – AP threshold) of repeated action
potentials measured at 3X rheobase for each cell. Line and shaded area represent
mean +/- SEM. The black bar indicates significance at p < 0.01 by a multivariate
ANOVA and post-hoc Bonferroni correction.
D) Bar graphs showing individual cell values (dots) and the population mean +/- SEM
for the maximal steady-state firing frequency of each cell (see methods). p values
determined by Mann–Whitney U test.
E) Bar graphs showing individual cell values (dots) and the population mean +/- SEM
for the reduction in spike amplitude of the tenth AP measured in B normalized to the
first AP. p values determined by Mann–Whitney U test. All comparisons consider
each cell as n = 1 (see Table S1 for per-animal comparisons).
F) Example images of WT VIP-INs showing immunohistochemical labeling of Nav1.1 on
putative axons originating either from the soma (i, inset iii) or a proximal dendrite (ii,
inset iv). Asterisks indicate regions of colocalization between Nav1.1 and tdT
expression in VIP-INs. Scale is 5 μm.

We identified a diversity of VIP-IN firing patterns in response to step
depolarizations consistent with previously described continuous adapting (CA), irregular
spiking (IS), and bursting cells (von Engelhardt et al., 2007; He et al., 2016; Lee et al.,
2010; Porter et al., 1998, 1999; Prönneke et al., 2015). However, when we delivered
longer (8-10 second) suprathreshold depolarizing pulses, we found that all cells could be
separated into two clear groups (Figure 2). Approximately half of all VIP-INs fired
continuously, albeit with spike frequency adaptation (here referred to as CA VIP-INs),
while the other half instead fired a burst of action potentials prior to switching to an
irregular spiking pattern (IS VIP-INs), often with a variable silent period in between the
two phases (Figure 2A). We could reliably identify these two groups using k-means
clustering of the length of the initial burst of action potentials and the coefficient of
variation of the inter-spike interval (ISI CoV), but these groups were not distinguishable
when using 600 ms pulses alone (Figure 2C,D). Many cells that fired continuously during
600 ms sweeps were in fact clearly IS based on response to these longer
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depolarizations; likewise, cells that might be classified as bursting and which appear to
cease firing during 600 ms sweeps eventually switch to an IS mode with longer
depolarizations.
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Figure 2. Two VIP-IN firing patterns revealed with long depolarization
A) Four representative cells displaying the range of VIP-IN firing patterns. On the left
are APs elicited with a standard (600 ms) current injection. On the right are firing
patterns recorded with 8 sec long depolarizations using the same current amplitude
as on the left (2X rheobase for each cell). CA and IS firing patterns are easily
separated with 8-second depolarization, but not distinguishable using only the first
600 ms. These firing patterns were consistent even when we stimulated with higher
current injections (see Figure 3Aii-iii).
B) Similar CA and IS patterns were observed in VIP-INs from Scn1a+/- mice, with a
deficit in IS VIP-IN firing.
C) Characterization of VIP-IN firing patterns using two key measures: the length of the
initial burst of action potentials, and the coefficient of variation of the inter-spike
interval (ISI CoV). These parameters were measured using either 600 ms or 8second long rectangular depolarization in cells from both WT and Scn1a+/- mice;
then, k-means clustering of the 8-second data was performed (light/dark colors
indicating the results of clustering into 2 groups). Note the clear separation between
the two groups in the 8-second data, but large overlap when looking only at data
generated from 600 ms current injections.
D) The same data as in C, but highlighting the dependence of the measured ISI CoV on
the length of the depolarization. With 600 ms sweeps, there is considerable overlap
between CA and IS cells in both genotypes; however, with 8 s depolarizations, the
two groups separate with minimal overlap.
E) Similar proportions of CA and IS cells in WT and Scn1a+/- mice. For C-E, n = 51 IS
and 63 CA from 24 WT mice, and n = 41 IS and 31 CA from 17 Scn1a+/- mice; p =
0.10 via chi-square test; chi-square statistic = 2.63.

A recent study implicated T-type calcium channels as the mechanism of bursting
at rheobase observed in a small subset (~20%) of VIP-INs (Prönneke et al., 2020). We
considered whether this group corresponded to the IS VIP-INs described here. A
prepulse step depolarization to -55 mV to inactivate T-type channels had no effect on the
suprathreshold response of IS-VIPs here (Figure S4 A-B). We were able to clearly
identify CA and IS VIP-INs using a slow 8-second ramp current injection to induce
inactivation of T-type calcium channels (Figure S4 C-E). Finally, we found that a subset
of both CA and IS VIP-INs burst at rheobase, indicating that our IS VIP-IN category does
not correspond directly to these previously described bursting VIP-INs (Figure
S5). Hence, we concluded that irregular spiking vs. bursting at rheobase are
mechanistically distinct features of in VIP-INs.
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Figure 3. IS VIP-INs are preferentially impaired in Scn1a+/- mice
A) i. Example traces of CA and IS VIP-INs from WT and Scn1a+/- mice, showing
responses at -50pA hyperpolarizing (gray), rheobase (black), and 2X rheobase
current injections (gray; typically ~100-140 pA). ii. Raster plots of all APs elicited with
standard 600 ms current steps in 10 pA increments for the cells in i. iii. Population
averages of the raster plots in ii, represented as heat maps where the color
corresponds to the instantaneous firing rate for each give current step using a 20 ms
sliding average.
B) Current/frequency (IF) plots for groups shown in A. Line and shaded area represent
mean ± SEM. Bar indicates p < 0.001 by a multivariate ANOVA and post-hoc
Bonferroni correction.
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C) Population average of AP amplitude for repeated action potentials elicited at 3X
rheobase for each cell. Line and shaded area represent mean ± SEM. Bar indicates
p < 0.001 by a multivariate ANOVA and post-hoc Bonferroni correction.
D) Bar graphs showing individual cell values (dots) and the population mean ± SEM for
several markers of VIP-IN excitability. p values determined by Kruskal-Wallis with
post-hoc Dunn’s test. For simplicity, differences between CA an IS cells are not
shown (see Table S1). For B-D, n = 71 IS and 78 CA cells from 32 WT mice, and n =
66 IS and 43 CA cells from 22 Scn1a+/- mice were included. All groups were
determined using 8-second square (Figure 2) or ramp depolarizations (Figure 5Figure supplement 1) or, for a subset of IS VIP-INs for which we did not record 8
second depolarizations, if their definitive firing pattern was clear with a 600 ms
depolarization (as in Ai).
IS VIP-INs are specifically impaired in Scn1a+/- mice
While VIP-INs exhibit decreased excitability in Scn1a+/- mice, dividing the data set
into CA and IS VIP-INs revealed that IS VIP-INs are particularly impaired while CA VIPINs are relatively spared. We determined that CA and IS VIP-INs are present in Scn1a+/and WT mice in similar proportions as determined by our unbiased classification (Figure
2B,E). IS VIP-INs displayed more severe deficits compared to the pooled dataset (Figure
1), with a depolarized AP threshold (WT vs. Scn1a+/- mice: -41.3 ± 0.5 vs. -39.3 ± 0.4; p
= 0.01), decreased AP amplitude (79 ± 1.0 vs. 72 ± 1.3 mV; p = 0.003) and steady-state
firing (59 ± 4 vs. 25 ± 3 Hz; p = 8 X E-9), a clear difference in the I-f curve, and notable
spike rundown with repetitive discharge (Figure 3). These differences remained
significant when we treated each animal (rather than a cell) as an n (Table S1). CA VIPINs from Scn1a+/- mice showed no statistical differences compared to CA VIP-INs from
age-matched WT littermate controls across a range of additional measures of intrinsic
excitability, properties of individual action potentials, and features of repetitive firing
(Table S1). Additionally, subtype differences between CA and IS VIP-INs were
consistent between WT and Scn1a+/- mice, including presence of increased voltage sag
in response to hyperpolarizing current injection and shorter (faster) AP half-width and
rise-time, with IS VIP-INs more likely to burst at rheobase (Figure S5, Table S1).
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As prior work showed that the electrophysiological abnormalities identified in PVINs in Scn1a+/- mice are limited to a narrow developmental window between P11-21
(Favero et al., 2018), we subdivided our analysis based on age and found nearly
identical results at P18-21 and P30-55 for both IS and CA VIP-INs (Figure S6). To
assess whether impairment of IS VIP-INs was a general phenomenon or restricted to
primary somatosensory neocortex, we additionally performed a set of recordings in layer
2/3 primary visual cortex, again finding a similar proportion of IS vs. CA VIP-INs and
replicating our central finding that IS VIP-INs were selectively hypoexcitable in Scn1a+/mice (Figure S7).

Modulation of Nav1.1 rescues IS VIP-IN function in Scn1a+/- mice
To further support our hypothesis that VIP-INs are impaired in Scn1a+/- mice due
to decreased expression of Nav1.1, we attempted to rescue VIP-IN function by directly
targeting Nav1.1 pharmacologically. Hm1a is a recently described spider toxin that
enhances Nav1.1 current via inhibiting fast and slow inactivation (Osteen et al., 2016,
2017). In acute brain slices prepared from Scn1a+/- mice, bath application of 1 µM Hm1a
led to markedly increased steady-state firing in IS VIP-INs (control, 33 ± 2 Hz; Hm1a, 97
± 5 Hz; p = 0.001) and attenuation of spike rundown (Figure 4A-C). We did observe an
effect in CA VIP-INs at this concentration, with a small increase in steady-state firing
frequency (control, 58 ± 4 Hz; Hm1a, 68 ± 5 Hz; p = 0.05) and attenuated spike height
accommodation. As a positive control, Hm1a increased the maximum steady-state firing
rate of PV-INs in Scn1a+/- mice at P18-21 (control, 229 ± 2 Hz; Hm1a, 292 ± 6 Hz; p =
0.004), although this effect was proportionally smaller than what we observed in IS VIP
INs (mean difference of 295% in IS VIP-INs compared to 28% in PV-INs). In contrast,
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Hm1a had no measurable effect on the firing of layer 2/3 neocortical pyramidal neurons
in WT mice, supporting the specificity of this toxin to Nav1.1 and the smaller role of
Nav1.1 in the regulation of pyramidal cell excitability relative to interneurons. We
repeated this rescue experiment of IS VIP-IN excitability using 50 nM Hm1a, which is
highly selective for Nav1.1 over other non-Nav1.1 Nav1.X subunits (Osteen et al., 2016;
Richards et al., 2018), and obtained identical results (Figure S8). Importantly, although
Hm1a causes a dramatic increase in steady-state firing of IS VIP-INs, these cells still
retain a distinct irregular firing pattern in the presence of Hm1a in response to longer
depolarizations (Figure S8).

Hm1a modulates Na+ current inactivation in VIP-INs
The mechanism of action of Hm1a involves destabilizing the inactive state of
Nav1.1, which increases the availability of Nav1.1 channels at depolarized potentials by
shifting more channels to the closed vs. inactive state. If VIP-INs indeed express Nav.1,
then Hm1a could lead to a rescue of IS VIP-IN function by preventing an accumulation of
Na+ channel inactivation during repetitive firing. To test this possibility, we directly
measured the effect of Hm1a on Na+ current in VIP-INs using whole cell voltage clamp
recordings of genetically labelled VIP-INs isolated from acutely dissociated cortex of P18
WT.VIP-Cre.tdT mice (Figure 4D-F). Hm1a slowed the time constant of inactivation and
increased slowly-inactivating/persistent current in VIP-INs, with no effect on the peak
current density. This further supports the presence of Nav1.1 in VIP-INs and indicates
that Hm1a has a similar effect on inactivation of endogenous Na+ current in VIP-INs as
compared to previously published data on Nav1.1 expressed in heterologous systems.
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Figure 4. Hm1a application modulates Na+ channels containing Nav1.1 subunits
in VIP-INs and recovers IS VIP-IN hypofunction in Scn1a+/- mice
A) Example traces from recordings of representative CA and IS VIP-INs from
Scn1a.VIP-Cre.tdT mice, as well as a PV-IN and pyramidal neuron from a Scn1a.PV39

B)

C)

D)

E)

F)

Cre.tdT mouse, before and after bath application of 1 μM Hm1a at a 3X rheobase
(near maximal) current injection for each cell. Note that the horizontal scale for the
PV-IN is 100 ms instead of 200 ms, to facilitate visualization of individual APs.
Change in the max steady state firing frequency of n = 9 CA VIP-INs, 7 IS VIP-INs, 6
PV-INs, and 3 pyramidal neurons from a total of 5 Scn1a.VIP-Cre.tdT and 2
Scn1a.PV-Cre.tdT P18-21 mice, with p values and significance determined using a
paired students’ t-test.
Spike amplitude of successive APs elicited at 3X rheobase for each cell. Line and
shaded area represent mean ± SEM, and bar indicates significance at p < 0.01 via a
multivariate ANOVA and post-hoc Bonferroni correction.
Example traces from voltage clamp recordings of VIP-INs from acutely dissociated
cortex of P18 WT.VIP-Cre.tdT mice. Light gray shows the initial transient Na+ current
recorded with a single voltage command step from -80 mV to 0 mV. Black shows the
response following bath application of 500 nM Hm1a. The dashed line indicates the
inset (shown on the right). There is no change in the peak amplitude, but clear
slowing of inactivation.
Example differential interference contrast image of a dissociated VIP-IN, as well as
the tdT signal imaged with epifluorescence. VIP-INs had small bipolar or rounded
shapes. Scale = 5 μM.
Quantification of the effects of Hm1a on n = 3 VIP-INs from 2 P18 WT.VIP-Cre.tdT
mice. Purple lines represent the change of each individual cell, with p values
determined by a paired students’ t-test.

Irregular spiking is not correlated with VIP-IN molecular markers
The rescue of IS VIP-IN excitability with Hm1a supports our conclusion that IS
VIP-INs are particularly impaired in Scn1a+/- mice. To attempt to understand how the
specific dysfunction of IS VIP-INs is involved in DS pathogenesis, we investigated
whether the IS and CA firing patterns identified here map onto previously described
morphological and molecularly defined VIP-IN subgroups. Intersectional Cre/Flp labeling
of VIP/cholecystokinin (VIP/CCK) or VIP/calretinin (VIP/CR) double positive INs defines
two minimally-overlapping subsets of VIP-INs (He et al., 2016; Porter et al., 1998). In
these mice, VIP/CR-INs have a bipolar morphology, while VIP/CCK INs tend to be
multipolar. We used whole cell recording with morphological analysis to compare our
electrophysiological classification scheme with the subtypes labeled via this
intersectional strategy (Figure 5). We filled cells with Alexa-488 during whole-cell
recording, generated 2P image stacks, and quantified the dendritic arborization pattern
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of each cell. VIP/CR-INs were more often bipolar, or “vertically biased,” compared to
VIP/CCK-INs (Figure 5A), as shown previously (He et al. , 2016), but CR and CCK did
not reliably define electrophysiological subtypes of VIP-INs (Figure 5A-B), nor were there
any differences in morphology between the CA and IS VIP-INs within a given genotype
(Figure 5C). This data argues that IS and CA firing patterns do not coincide with
previously described VIP-IN subgroups.
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Figure 5. Intersectional expression of CR and CCK labels anatomical subsets of
VIP-INs but does not correlate with IS vs. CA firing patterns.
A) Example traces from layer 2/3 VIP-INs in barrel cortex of adult CR-Cre/VIP-Flp and
CCK-Cre/VIP-Flp mice. Both CA and IS firing patterns were observed in each
intersectional population of VIP-INs. Insets on the left show the first 600ms of each
8-second depolarization.
B) Morphological reconstruction of the proximal dendrites of the cells in A to illustrate
dendritic orientation. Scale is 100 μm. The adjoining histogram quantifies the
proportion of total dendrite that lies within or outside of 30° from vertical
(perpendicular to the pial surface). Black axes indicate the length of histogram
corresponding to 100%.
C) Proportion of CR and CCK VIP-INs that are CA vs. IS (n = 17 total VIP-INs from 3
CR-Cre/VIP-Flp mice and n = 19 VIP-INs from CCK-Cre/VIP-Flp mice); p > 0.1 by
Chi-square test.
D) Individual cells (dots) and population mean ± SEM for the vertical bias of each cell
calculated from the morphological reconstructions in B. Vertical bias is the percent of
dendrite within 30° of the line perpendicular to the pial surface, with a value of 1
corresponding to a perfectly bipolar shape. CA and IS VIP-INs in CR-Cre/VIP-Flp
mice are mostly bipolar, with high vertical bias; CA and IS VIP-INs from CCKCre/VIP-Flp mice are multipolar, with vertical bias of ~ 0.5. Traditional Scholl analysis
did not clearly illustrate this key difference between VIP-INs.

Irregular spiking of VIP-INs is determined by M-current
Despite the negative finding above, we were interested in the molecular
determinants of the IS discharge pattern to better understand why IS VIP-INs are
selectively impaired in Scn1a+/- mice. The firing pattern of IS VIP-INs could suggest the
presence of a slowly activating potassium conductance in these cells. M-current,
mediated by KCNQ channels, is known to possess such properties and has been
hypothesized to regulate mode switching between tonic and bursting/irregular firing
(Drion et al., 2010; Stiefel et al., 2013). Single-cell transcriptomics data suggests
relatively high expression of the KCNQ subunit Kcnq5 in a subset of VIP-INs, including
approximately half of all VIP/CR and VIP/CCK-INs, with minimal expression in either PV
or SST-INs. KCNQ subfamily member Kcnq2 is more broadly expressed across all INs,
while Kcnq1/3/4 show very limited cortical expression (Figure S9, Paul et al., 2017; Tasic
et al., 2016). We confirmed these data using immunohistochemistry for Kcnq5 and
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Figure 6. KCNQ channels regulate VIP-IN firing patterns
A) Example traces from representative CA and IS VIP-INs in response to 8-second
depolarization at 2X rheobase before and after bath application of either the KCNQ
activator retigabine (left) or inhibitor linopirdine (right), respectively.
B) The response of n = 7 CA and n = 8 IS cells from 4 WT.VIP-Cre.tdT mice to the
above drug application. Arrows indicate the direction of change in ISI CoV value and
burst length (as in Figure 2C) after drug appliction, with the base of the arrow
corresponding to the initial measurment, and the arrowhead corresponding to the
values measured after drug application.
C) Mean ± SEM of each value in B before and after drug application, with p-values and
significance determined by a paired students t-test.
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Kcnq3. Kcnq5 was expressed in ~40% of layer 2/3 VIP-INs and essentially no SST-INs
(but was expressed in many presumptive pyramidal cells), while Kcnq3 showed very
limited immunoreactivity in the superficial cortex overall and was not found on VIP-INs
(Figure S10).
Based on this data, we hypothesized that M-current mediated by Kcnq5containing KCNQ channels underlies irregular spiking in IS VIP-INs, while CA VIP-INs
do not rely on M-current for their firing properties. Using KCNQ channel-specific
pharmacology, we were able to bidirectionally modulate the firing patterns of IS and CA
VIP-INs, interconverting firing patterns by either blocking or activating M-current with the
KCNQ channel inhibitor linopirdine or the KCNQ channel activator retigabine,
respectively (Figure 6). IS VIP-INs showed a marked increase in sustained firing with the
addition of linopirdine and resembled CA VIP-INs in terms of burst length and ISI CoV.
Conversely, some CA VIP-INs became “IS-like” upon application of retigabine. However,
linopirdine had essentially no effect on CA VIP-IN excitability or intrinsic properties
(Figure S11) indicating that whatever M-current is present in these cells is not a major
regulator of cellular excitability. Such data indicates that M-current expression is a critical
but selective determinant of the electrical excitability of IS VIP-INs. However, M-current
does not seem to correlate with expression of VIP-IN markers such as CR and CCK, or
with VIP-IN morphology.

Cholinergic switching from irregular to continuous firing in VIP-INs
VIP-INs are strongly recruited by ascending cholinergic modulation in vivo (Fu et
al., 2014), and M-current is characteristically inhibited by muscarinic receptor activation
(Brown and Passmore, 2009). Therefore, we hypothesized that acetylcholine would
activate IS VIP-INs and induce switching to a continuous firing mode. Bath application of
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Figure 7. Cholinergic modulation induces switching from irregular to continuous
firing in IS VIP-INs
A) Depolarization in resting membrane potential of IS and CA VIP-INs with bath
application of 5 μM Carbachol. Horizontal scale bar, 1 minute. In addition to
membrane depolarization, there was a notable increase in synaptic activity, and in
some cases spontaneous firing. Population mean ± SEM of the change in membrane
potential was 13 ± 5 and 10 ± 5 mV for IS and CA VIP-INs respectively (p > 0.05).
B) Action potential trains elicited with 8-second long square depolarizations at 2X
rheobase current injections before, during, and after washout of 5 μM carbachol. In
each case, the membrane potential was offset to -70 mV by direct current injection.
Scale bars, 40 mV and 1 second. Insets showing no change in the initial bursting
characteristics at suprathreshold current injections with the application of carbachol.
Scale bars, 40 mV and 50 ms.
C) Quantification of changes in firing patters of n = 7 IS and n = 8 CA VIP-INs from 3
WT.VIP-Cre.tdT mice in response to carbachol. All IS cells showed a qualitative
switch to a continuous firing mode represented by increased burst length and
decreased ISI CoV (indicated by arrowheads as in Figure 6); p-values determined by
paired students’ t-test. There were no apparent changes in CA VIP-IN firing patterns
with carbachol application (arrowheads omitted for clarity).
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the cholinomimetic carbachol (5 μM) produced a 10-15 mV depolarization in both CA
and IS VIP-INs (Figure 7A). However, the suprathreshold firing properties of IS VIP-INs
again converted to a “CA-like” pattern, firing for a full 8-second depolarizing pulse with
decreased irregularity. There was essentially no effect on the firing pattern of CA VIPINs, nor was there any effect on the initial bursting characteristics of either IS or CA VIPINs (Figure 7B,C). The effect of carbachol closely resembled the effect of linopirdine on
IS VIP-INs. Similarly, we found that muscarinic, but not nicotinic stimulation, induced
tonic firing in IS VIP-INs, while both types of cholinergic stimulation independently
produced membrane potential depolarization of similar magnitude (4.24 ± 0.7 mV for
muscarinic vs. 5.48 ± 1.4 mV for nicotinic; p > 0.05; Figure S12). Hence, M-current
inhibition via activation of muscarinic acetylcholine receptors represents a novel
mechanism of neuromodulation in VIP-INs that is separate from the recently described
tonic depolarization caused by nicotinic acetycholine receptor activation (Askew et al.,
2019).

A single compartment model recapitulates the interaction between M-current and
Na+ current density in the determination of VIP-IN discharge pattern
Taken together, evidence for a broad distribution of Scn1a across INs from RNA
sequencing data, our own immunohistochemistry showing Nav1.1 protein on the axon of
most VIP-INs, as well as the response of both IS and CA VIP-INs to Hm1a, suggests
that Nav1.1 is likely present in both IS and CA VIP-INs, but that action potential
generation in IS VIP-INs is more affected by heterozygous loss of Nav1.1. This could be
due to a combination of lower non-Nav1.1-mediated Na+ current in IS VIP-INs (such that
these cells are more reliant on Nav1.1 for spike generation and repetitive firing),
combined with relatively higher expression of M-current mediated by Kcnq5-containing
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KCNQ channels. To explore this question, we constructed a classic Hodgkin-Huxley (HH) single compartment model, adding a slowly activating potassium current (gKS) to
simulate the influence of M-like current (Stiefel et al., 2013) in VIP-INs (Figure 8).

After setting the standard H-H parameters to approximate the firing pattern of a
typical WT CA VIP-IN (see Materials and Methods), we increased M-current density to
produce a response qualitatively similar to WT IS VIP-INs. Then, we performed a
parameter sweep, varying both the M-current and Na+ current density to simulate the
effect of loss of one copy of Scn1a in the presence or absence of M-current. Reducing
Na+ current by up to 50% in models with little or no M-current had only minor effects on
excitability (Figure 8), similar to our recordings from CA VIP-INs in Scn1a+/- mice.
However, in models with increasing amounts of M-current, reducing Na+ current density
had a progressively more dramatic effect, leading to action potential failure after only a
few action potentials (Figure 8), similar to what we observed experimentally in Scn1a+/IS VIP-INs. Therefore, both the CA and IS-VIP firing patterns that characterize VIP-IN
diversity, as well as the effect of loss of one copy of Scn1a, are captured in a simple
model with continuous distributions of both Na+ and M-current. This supports our
conclusion that most or all VIP-INs express Nav1.1, and that IS VIP-INs – which have a
prominent M-current mediated by Kcnq5-containing KCNQ channels – are selectively
dysfunctional in Scn1a+/- mice.
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Figure 8. Single compartment model of a VIP-IN illustrates the interaction between
M-current and Na+ current
A single compartment Hodgkin-Huxley style conductance-based model using standard
differential equations. Heat map indicates firing frequencies elicited with a 600 ms X 100
pA test pulse on a linear scale. The model was initially modified to approximate the
intrinsic properties and firing rate of a typical WT CA VIP-IN observed experimentally. A
slowly activating K+ current with a fixed time constant (gKS) was then added to
approximate the presence of M-current; in the presence of Gaussian distributed noise,
this induced irregular spiking similar to that seen in IS VIP-INs (top right). Then, the
amount of total Na+ current density (gNa) in the model was varied. Models with low gNa
and little or no gKS showed minimal impairment with a ~10-20% decrease in spike
height and firing frequency. Models with low gNa and medium to high levels of gKS
showed much more profound impairment, with complete collapse of repetitive action
potential generation.
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DISCUSSION
VIP-INs express Nav1.1 and are hypoexcitable in Scn1a+/- mice
VIP-INs exhibited impaired action potential generation in Scn1a+/- mice consistent
with decreased Na+ channel expression, and this deficit could be rescued with the
Nav1.1-specific modulator Hm1a, supporting the presence of Nav1.1 subunit-containing
Na+ channels in VIP-INs. We found that these deficits were localized to a large subset of
VIP-INs that exhibited irregular spiking (IS). This basic finding was consistent across
cortical areas, and, importantly, was seen at early developmental time points (P18-21)
as well as in juvenile/young adult mice (P30-55). Interestingly, Hm1a had a larger effect
on IS VIP-INs than on PV-INs, consistent with the observation that IS VIP-INs may be
more profoundly impaired than PV-INs in Scn1a+/- mice. This persistent VIP-IN
dysfunction in Scn1a+/- mice is distinct from the time course of PV-IN dysfunction, which
we previously found is transient and delimited to an early developmental period when
assessed via the same approach (Favero et al, 2018). Such a time course is consistent
with the known natural history of Dravet syndrome in human patients: it is well
established that seizure frequency typically decreases during early childhood, while
cognitive deficits remain, with moderate to severe intellectual disability and features, or a
formal diagnosis of, autism spectrum disorder (Berkvens et al., 2015; Genton et al.,
2011; Han et al., 2012; Li et al., 2011). As VIP-INs are considered to have a role as
disinhibitory elements in cortical circuits, it might seem counterintuitive that such cells
might be dysfunctional in an epilepsy syndrome; however, it may be the case that early
epilepsy in driven by transient PV-IN abnormalities while cognitive impairment persists in
part due to ongoing VIP-IN hypofunction.
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Two distinct firing patterns of VIP-INs revealed by response to long depolarization
Previous studies have demonstrated a diversity of VIP-IN electrophysiological
properties that do not clearly correlate with other molecular and anatomical markers of
VIP-INs (von Engelhardt et al., 2007; He et al., 2016; Kawaguchi and Kubota, 1997;
Porter et al., 1998; Prönneke et al., 2015). We also observed a seemingly diverse range
of firing patterns in VIP-INs that did not clearly correlate with anatomy or proposed VIPIN molecular markers CR and CCK (Figure 5). Using the response to longer (8-10 sec)
depolarizations, k-means clustering facilitated clear division into two electrophysiological
groups, which we refer to as IS and CA VIP-INs (Figure 2; Porter et al., 1999), each of
which comprise approximately 50% of VIP-INs in layer 2/3 in both barrel cortex and V1
at both P18-21 and P0-55. IS and CA firing patterns were robust to a variety of
stimulation protocols, including a slow ramp current injection and prepulse step
depolarization to inactivate T-type calcium currents that underlie burst firing in a subset
of VIP-INs (Prönneke et al., 2020) (Figure 5-Figure supplement 1). Therefore, irregular
spiking is distinct from, yet partially overlaps with, bursting. However, our data clearly
indicated that brief current pulses on the order of hundreds of milliseconds (such as are
standard in slice physiology experiments) cannot establish whether a VIP-IN is IS or CA,
as many IS VIP-INs fire continuously for 600 ms or more prior to transition to an IS
pattern. This distinction may be relevant for ongoing efforts to create a comprehensive
classification of VIP-INs (Gouwens et al., 2018; He et al., 2016; Prönneke et al., 2015,
2020). It will be important to investigate the physiological relevance of differences in
firing patterns identified in acute brain slice experiments and how this relates to the in
vivo activity of VIP-INs. While the stimuli used here are very different than naturalistic
stimuli in the intact organism, such experiments reveal details related to the complement
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of ion channels expressed by VIP-INs as well as modulation by neurotransmitters that
may be highly relevant in vivo.

M-current mediated by Kcnq5-containing K+ channels regulates VIP-IN excitability
and mediates response to cholinergic neuromodulation
We divided VIP-INs into IS and CA cells based on the presence of an initial
period of regular firing followed by a suppression of firing and subsequent irregular
spiking (as define by a high ISI coefficient of variation). This pattern suggested the
expression of a slowly-activating potassium current such as M-current (Brown and
Passmore, 2009). Transcriptomics data supports our finding that most VIP-INs express
Nav1.1 and suggests that a subset of VIP-INs express the KCNQ channel subunit Kcnq5
(Paul et al., 2017; Tasic et al., 2016), which we confirmed with immunohistochemistry
(Figure 6- Figure supplement 2). We hypothesized that M-current in IS VIP-INs drives
this distinctive firing pattern, with CA VIP-INs express low levels of M-current that is
insufficient to induce irregular firing. We were able to bidirectionally modulate VIP-IN
firing patterns by pharmacologically blocking or enhancing M-current in IS and CA VIPINs respectively, supporting this hypothesis. However, the level of M-current in CA VIPINs appears to be small enough such that blocking M-current in these cells has no effect
on their firing properties (Figure S11). Even though our classification highlighted
prominent differences in excitability, most or all VIP-INs do appear to express some level
of both Nav1.1 and Kcnq2/5. It is possible that the electrophysiological properties of VIPINs defined here do not constitute clearly delimited ‘subtypes’ per se, but rather exist
along a continuum of active properties which only partially overlap with molecular
markers (such as CR and CCK) and morphology. Nevertheless, an irregular firing
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pattern that can be modulated by cholinergic suppression of M-current appears to be a
durable feature of ~50% of VIP-INs.

If Kcnq5 and Nav1.1 in VIP-INs have overlapping distributions of expression, how
does Scn1a haploinsufficiency lead to selective dysfunction of IS VIP-INs? To address
this, we constructed a single compartment model with a voltage-gated Na+ conductance
and M-type K+ conductance to simulate the influence of superimposed M-current on
neuronal excitability in the context of varied Na+ current density. This modelling
recapitulated several important characteristics of our data, including the diversity of VIPIN firing patterns, the role of M-current in this diversity, and the interaction between Na+
current and M-current. The model illustrates how loss of Nav1.1 could have drastically
different effects in IS vs. CA VIP-INs based on electrophysiological context, such as the
overall level of M-current and the degree of reliance on Nav1.1.

VIP-INs are recruited during shifts in attentional state, and their activity is
important for the cortical state transition that occurs in response to cholinergic
neuromodulation (Batista-Brito et al., 2017; Fu et al., 2014; Reimer et al., 2014; Walker
et al., 2016). Our data suggests that cholinergic input may enhance VIP-IN excitability
during cortical state transitions by inhibiting M-current. We found that, while application
of carbachol depolarized both IS and CA VIP-INs, this manipulation selectively
modulates IS VIP-IN excitability by inducing a switch from IS to tonic firing mode through
muscarinic acetylcholine receptor activation. This effect may be important during shifts in
attentional state, which are known to recruit VIP-IN activity. Our data also implies that IS
VIP-IN dysfunction in Scn1a+/- mice may play a particularly important role in the activity
of IS VIP-INs during such state changes. Overall, our findings identify a novel cellular
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locus of dysfunction in Dravet Syndrome which may be relevant to both the epilepsy and
the severe cognitive impairments characteristic of this disease.
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MATERIALS AND METHODS
Table 1. Key Resources
Reagent type
Source or
(species) or

Designation

Additional
Identifiers

reference

information
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Genetic

129S-

reagent (M.

Scn1atm1Kea/Mmja

musculis)

x

Dr. Jennifer A.

MRRC_0

Kearney,

37107-

Northwestern

JAX

University

Jax

Genetic
reagent (M.

RRID:M

RRID:IM
Viptm1(cre)Zjh/J

Jax

musculis)

SR_JAX:
010908

Genetic

RRID:IM
B6;129P2Jax

reagent (M.

SR_JAX:

Pvalbtm1(cre)Arbr/J
musculis)

008069

Genetic

B6J.Cg-

RRID:IM

reagent (M.

Ssttm2.1(cre)Zjh/Mw Jax

SR_JAX:

musculis)

arJ

028864

Genetic

RRID:IM
Rosa- CAG-LSLJax

reagent (M.

SR_JAX:

tdTomato
musculis)

007914
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Genetic

RRID:IM
Taconic

reagent (M.

129S6.SvEvTac

SR_TAC:
Biosciences

musculis)

129sve

Genetic

RRID:IM

reagent (M.

C57BL/6J

Jax

SR_JAX:

musculis)

000664

Genetic

RRID:IM

Drs. Bernardo

SR_JAX:

Rudy and Robert

012706

Machold, NYU

RRID:IM

Drs. Bernardo

SR_JAX:

Rudy and Robert

musculis)

010774

Machold, NYU

Genetic

RRID:IM

Drs. Bernardo

SR_JAX:

Rudy and Robert

028578

Machold, NYU

RRID:IM

Drs. Bernardo

SR_JAX:

Rudy and Robert

025109

Machold, NYU

reagent (M.

Ccktm1.1(cre)Zjh/J

Jax

musculis)
Genetic
B6(Cg)Jax

reagent (M.
Calb2tm1(cre)Zjh/J

reagent (M.

Viptm2.1(flpo)Zjh/J

Jax

musculis)
B6.CgGenetic
Gt(ROSA)26Sortm8
Jax

reagent (M.
0.1(CAGCOP4*L132
musculis)
C/EYFP)Hze/J
recombinant

AAV.CAG.Flex.tdTo

Penn

AV-9-

DNA reagent

mato

Vector Core

ALL864

2XE+13 GC/mL
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peptide,
recombinant

Hm1a

Alomone

STH-601

1 µM / 50 nM

protein
chemical

A12924

Biocytin conjugated
Invitrogen

compound,

0.5%

to Alexa Fluor 488
drug
chemical
compound,

Linopirdine

Sigma

L134

50 µM

Retigabine

Alomone

D-23129

50 µM

Sigma

C4382

5 µM

Sigma

M6532

5 µM

Tocris

0352

1 µM

drug
chemical
compound,
drug
chemical
Carbamoylcholine
compound,
chloride
drug
chemical
compound,

Muscarine

drug
chemical

4-Acetyl-1,1-

compound,

dimethylpiperaziniu

drug

m iodide
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software,
Pclamp 10

Clampfit

V10.0

Matlab

Mathworks

2019a

doi.org/10.2

Data

1105/joss.0

visualization for

0568

Matlab

algorithm
software,
algorithm

software,
Gramm
algorithm

Anti-Nav1.1 sodium
Antibody

channel, clone

NeuroMab

75-023

1:500, IF

K74/71
KCNQ5 Polyclonal
Antibody

PA5Invitrogen

Antibody
Anti-KCNQ3

Alomone

Antibody
Antibody

1:500, IF
77651

APC-051

1:200, IF

Invitrogen

A-21121

1:1000, IF

Invitrogen

A-11008

1:1000, IF

labs

Goat anti-Mouse
IgG1 CrossAntibody

Adsorbed
Secondary Antibody,
Alexa Fluor 488

Antibody

Goat anti-Rabbit IgG
(H+L) Cross-
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Adsorbed
Secondary Antibody,
Alexa Fluor 488
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Experimental animals
All procedures and experiments were approved by the Institutional Animal Care
and Use Committee at the Children’s Hospital of Philadelphia and were conducted in
accordance with the ethical guidelines of the National Institutes of Health. Both male and
female mice were used in equal proportions. After weaning at P21, mice were grouphoused with up to 5 mice per cage and maintained on a 12-hour light/dark cycle with ad
libitum access to food and water.
Mouse strains used in this study included: Scn1a+/- mice on a 129S6.SvEvTac
background (RRID:MMRRC_037107-JAX) generated by a targeted deletion of exon 1 of
the Scn1a gene, VIP-Cre mice (Viptm1(cre)Zjh/J; RRID:IMSR_JAX:010908 on a mixed
C57BL/6;129S4 background), PV-Cre mice (B6;129P2-Pvalbtm1(cre)Arbr/J;
RRID:IMSR_JAX:008069), SST-Cre mice (B6J.Cg-Ssttm2.1(cre)Zjh/MwarJ;
RRID:IMSR_JAX: 028864), tdTomato reporter/Ai14 mice (Rosa- CAG-LSL-tdTomato;
RRID:IMSR_JAX:007914; on a C57BL/6J background), wild-type 129S6.SvEvTac
(Taconic Biosciences model #129SVE; RRID:IMSR_TAC: 129sve), and wild-type
C57BL/6J (RRID:IMSR_JAX:000664).
Homozygous VIP-Cre mice were crossed to homozygous Ai14 mice to generate
VIP-Cre.tdT double heterozygotes on a predominantly C57BL/6J background. Female
VIP-Cre.tdT double heterozygotes were then crossed to male 129S6.Scn1a+/- mice to
generate Scn1a.VIP-Cre.tdT mice and WT.VIP-Cre.tdT littermate controls. The genotype
of all mice was determined via PCR of tail snips obtained at P7 and was re-confirmed for
each mouse after they were sacrificed for slice preparation. The same breeding scheme
was used to generate Scn1a.PV-Cre.tdT (as in Favero et al, 2018). All mice used for
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experiments were on a near 50:50 129S6:B6J background, and Scn1a+/- mice on this
background have been shown to replicate the core phenotype of Dravet Syndrome
(Miller et al., 2014; Mistry et al., 2014). We observed similar rates of spontaneous death
(17/52, or 32%, of Scn1a.VIP-Cre.tdT mice not used for experiments by P55; Favero et
al., 2018) and were able to thermally induce seizures in 100% (9/9) of P21-50
Scn1a.VIP-Cre.tdT mice at or below 42°C core body temperature, supporting the validity
of using these mice as a tool to study VIP-IN function in Dravet Syndrome.
We used an intersectional genetic approach (He et al., 2016; Taniguchi et al.,
2011) to target CCK and CR expressing VIP-INs. These mice were a cross between
either CCK-Cre (Ccktm1.1(cre)Zjh/J; RRID: IMSR_JAX:012706) or CR-Cre (B6(Cg)Calb2tm1(cre)Zjh/J; RRID: IMSR_JAX:010774) crossed to a VIP-Flp
(Viptm2.1(flpo)Zjh/J; RRID: IMSR_JAX:028578) and fluorescent reporter Ai80 (B6.CgGt(ROSA)26Sortm80.1(CAG-COP4*L132C/EYFP)Hze/J; RRID: IMSR_JAX:025109).
Stereotaxic injections
In a subset of experiments at the P35-50 age, VIP-INs from double transgenic
Scn1a.VIP-Cre and WT.VIP-Cre littermates from the cross described above were
labeled via stereotaxic injection of AAV.CAG.Flex.tdTomato (Penn Vector Core, AV-9ALL864) at approximately P25. Briefly, P25 mice were anesthetized with isoflurane
(induction, 3-4%; maintenance, 1-1.5%) and body temperature and breathing were
continuously monitored. A small craniotomy approximately 1 mm posterior and 3 mm
lateral to bregma was made to allow insertion of a 50-75 μm tip diameter glass pipette
driven by a Nanoject III (Drummond Scientific). 100 nL of 2XE+13 GC/mL of AAV9
diluted in sterile PBS was injected at 20 nL/min. The pipette was held in place for 10 min
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to allow the virus to spread, and was then slowly removed; the scalp was sutured closed,
and the mouse allowed to recover.
Acute slice preparation
Mice were anesthetized with isoflurane and transcardially perfused with ice cold
artificial cerebral spinal fluid (ACSF) containing (in mM): NaCl, 87; sucrose, 75; KCl, 2.5;
CaCl2, 1.0; MgSO4, 6.0; NaHCO3, 26; NaH2PO4, 1.25; glucose, 10, and equilibrated with
95% O2 and 5% CO2. The brain was removed to cold ACSF, then mounted on a holder
of the Leica VT-1200S vibratome and sliced at 300-350 μm thickness. Slices were
allowed to recover for 30 minutes in ACSF warmed to 30°C, then maintained at room
temperature for up to 6 hours before recording. Slices were transferred to a recording
chamber on the stage of a BX-61 upright microscope and continuously perfused with
recording solution at 30-32° C and 3 mL/min that contained, in mM: NaCl, 125; KCl, 2.5;
CaCl2, 2.0; MgSO4, 1.0; NaHCO3, 26; NaH2PO4, 1.25; glucose, 10.
Slice recordings
VIP-INs and PV-INs were identified by tdT expression visualized with
epifluorescence. Pyramidal cells were identified by morphology under infrared differential
interference contrast (IR-DIC) and the presence of a regular-spiking firing pattern.
Whole-cell recordings were obtained from superficial (layer 2/3) primary somatosensory
cortex (S1; “barrel”) and visual cortex (V1) with between 1 – 4 (usually 1 or 2) cells
recorded from each slice in either single or paired configuration. Patch pipettes were
pulled from borosilicate glass using a P-97 puller (Sutter Instruments) and filled with
intracellular solution containing (in mM): K-gluconate, 130; KCl, 6.3; EGTA, 0.5; MgCl2,
1.0; HEPES, 10; Mg-ATP, 4.0; Na-GTP, 0.3; pH was adjusted to 7.30 with KOH, and
61

osmolarity adjusted to 285 mOsm with 30% sucrose. Where indicated, intracellular
solution also contained 0.5% biocytin conjugated to Alexa Fluor 488 (Invitrogen) for 2P
imaging. Pipettes had a resistance of 4-6 MΩ when filled and placed in recording
solution. Voltage was sampled at 50 kHz with a MultiClamp 700B amplifier (Molecular
Devices), filtered at 10 kHz, digitized using a DigiData 1550A, and acquired using
pClamp10 software. Recordings were discarded if the cell had an unstable resting
membrane potential and/or a membrane potential greater than -50 mV, or if access
resistance increased by > 20% during the recording. We did not correct for liquid junction
potential.
Electrophysiology data analysis
All analysis was performed blind to genotype using custom written Matlab
(Mathworks) code with quality control using manual confirmation in Clampfit (pCLAMP).
Resting membrane potential (Vm) was calculated using the average value of a 1 s sweep
with no direct current injection. Input resistance (Rm) was calculated using the average
response to small hyperpolarizing current injections near rest using Rm = ΔV/I for each
sweep. AP threshold was calculated as the value at which the derivative of the voltage
(dV/dt) first reached 10 mV/ms. Spike height refers to the absolute maximum voltage
value of an individual AP, while spike amplitude was calculated as the difference
between spike height and AP threshold for a given AP. AP rise time is the time from AP
threshold to the peak of the AP. AP half-width (AP 1⁄2-width) is defined as the width of
the AP (in ms) at half-maximal amplitude (half the voltage difference between the AP
threshold and peak). AP afterhyperpolarization (AHP) amplitude is calculated as the
depth of the afterhyperpolarization (in mV) relative to AP threshold. Unless indicated, all
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quantification of single spike properties was done using the first AP elicited at rheobase
(below).
Rheobase was determined as the minimum current injection that elicited APs
using a 600 ms sweep at 10 pA intervals. Maximal instantaneous firing was calculated
using the smallest interspike interval (ISI) elicited at near-maximal current injection.
Maximal steady-state firing was defined as the maximal mean firing frequency during the
last 300 ms of a suprathreshold 600 ms current injection, with a minimum requirement
for a spike being an amplitude of 40 mV with a clear AP threshold (above) and height
overshooting at least -10 mV. We found the combination of these two measures to best
describe VIP-IN firing rates, as some cells fired a very brief burst of APs at high
frequency, while others fired continuously with little or no initial bursting. All I-f plots were
created using the steady-state firing calculated for each current step, counting failures as
0 for subsequent current steps. Population raster plots were constructed by taking a 20
ms sliding average of the instantaneous firing rate for each current step and averaged
over each group of cells.
Firing pattern classification
We used a longer depolarizing current injection (generally, 8-10 s) which was
found to highlight features of VIP-IN firing that were not apparent with briefer, 600 ms
current injections. The coefficient of variation of the ISI (ISI CoV) was used to quantify
irregularity of repetitive AP discharge, and was defined as the standard deviation divided
by the mean of all ISI’s from a single 8 s or 600 ms sweep at 2-times rheobase current
injection. The burst length of a cell was defined by taking the time of the last spike
occurs prior to an abrupt cessation of firing lasting > 150 ms. This value was determined
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in an unbiased way by taking the mean + 2-times standard deviation of all ISI values
from our data set. We used the same cutoff to calculate an “apparent” burst length when
using data from 600 ms sweeps. We used k-means clustering with n = 2 groups to
cluster VIP-INs from both WT and Scn1a+/- mice using the variables of ISI CoV and burst
length from 8 s current injections at 2-times rheobase. Clustering was validated with >
95% agreement with blind manual classification when dividing cells based on the
provided description of continuous firing with spike frequency adaptation (“CA”) versus
initial burst followed by irregular spiking (“IS”). It was not possible to use 600 ms sweeps
alone to replicate these two groups, either with k-means clustering of
electrophysiological properties or manual classification.
Voltage clamp recordings of acutely dissociated cells
We performed voltage clamp recordings from acutely dissociated cells prepared
from neocortex of P18 WT.VIP-Cre.tdT mice. Briefly, the mouse brain was extracted into
ice cold ACSF as described above. Then, 400 μm slices were cut on a vibratome, and
the neocortex was manually separated from the underlying white matter using a scalpel.
All neocortical sections were simultaneously place in dissociation media (Earl’s balanced
salt solution (EBSS)) with (in mM): NaCl, 117; KCl, 5.0; NaHCO3, 26; NaH2PO4, 1.0;
CaCl2, 1.0; MgSO4, 4.0; HEPES, 20; glucose, 10, equilibrated with 95% O2:5% CO2, and
pH adjusted to 7.4 with NaOH. This was supplemented with 0.1% trypsin (Sigma), 1
mg/mL collagenase (Sigma), 100 U/mL DNAse1 (Sigma), and incubated for 10 min at
35° C. Dissociation was quenched by pouring the contents into a large volume of room
temperature ACSF, and the neocortical sections were maintained for up to 4 hours. Prior
to recording, individual sections were manually dissociated by triturating with a series of
fire-polished glass pipettes decreasing in size, then immediately plated on a glass
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coverslip coated in poly-D lysine (Sigma). Cells were allowed to settle and adhere for 10
min, then the ACSF was exchanged for recording solution containing (in mM): NaCl,
135; KCl, 4; CaCl2, 2; MgCl2, 2; HEPES, 10; Glucose, 10; TEA-Cl, 10; CdCl2, 0.1; with
pH adjusted to 7.4 with NaOH. VIP-INs were identified with epifluorescence. Cells were
recorded with patch pipettes with a resistance measured at 2.5-3.0 MΩ containing (in
mM): NaF, 10 CsF, 110; CsCl, 20; EGTA, 2; HEPES, 10; with pH adjusted to 7.4 with
KOH. Na+ currents were recorded in cells that were stable and had an access resistance
< 10 MΩ for 5 minutes after break in using a series of 100 ms voltage steps from -80 to
50 mV. Peak current was calculated as the max absolute value of the current response.
Persistent current was calculated as a percentage of transient current using the mean
current during the period between 80 and 100 ms after the initial voltage step. The time
constant of inactivation (tau) was calculated by fitting a double exponential to the decay
of the Na+ current, reporting the value for the dominant term. All values in Figure 4 were
calculated using the current elicited at 0 mV.
Immunohistochemistry
To facilitate staining of Nav1.1 at the AES, we used very mild fixation (1%
paraformaldehyde with 0.5% MeOH in PBS) described previously (Alshammari et al.,
2016). Briefly, isoflurane-anesthetized mice were transcardially perfused; brains were
removed and post-fixed in perfusate at RT for 1 hour. We then immediately cut 50 µm
sections on a Leica VT-1200S vibratome, and then blocked and permeabilized the slices
with 0.5% Triton X-100 (Sigma) and 10% normal goat serum in PBS for one hour at RT.
We stained overnight at 4° C with a primary antibody directed against Nav1.1
(NeuroMab K74/71) in PBS with 3% bovine serum albumin (BSA, Sigma) and 0.5%
Triton X-100. The following day, the slices were washed with PBS and stained with a
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secondary antibody, Alexa Fluor 488-conjugated goat anti-mouse IgG1 (Molecular
Probes), in PBS, with 3% BSA and 0.5% Triton X-100. After washing, slides were coverslipped and sealed before imaging on a Leica TCS SP8 confocal microscope. We
examined VIP-INs under 80X magnification and detected Nav1.1 signal on very fine (0.5
m) processes emanating from either the cell body or proximal dendrite. We used a
cutoff of mean + 2-times the standard deviation of the Nav1.1 signal measured using
repeated line scans on at least 5 μm (consecutive) of tdT-positive VIP-IN processes to
define a “positive” VIP-IN axon. For verification of Nav1.1 antibody specificity, we
generated several Scn1a-/- mice by breeding two Scn1a+/- mice. For Kcnq3/5 staining,
we used standard 4% paraformaldehyde, then performed staining as described above.
Allen Brain data access
Data was accessed directly from: © 2015 Allen Institute for Brain Science. Allen
Cell Types Database. Available from: celltypes.brain-map.org/rnaseq. This data
represents over 20,000 cells pooled from primary mouse visual cortex (V1) and anterior
lateral motor cortex (ALM). The provided RNA-Seq Data Navigator was used to restrict
data selection to pyramidal cells and VIP-INs from layer 2/3 to match our experimental
data. SST and PV-INs from all layers were also included as a reference. ScnXa, KcnqX,
Cck, and Calb2 expression levels were downloaded in February 2019 from the indicated
cell types for offline analysis and plotting using Matlab.
Slice pharmacology
We used several pharmacological agents including Hm1a (Alomone Labs STH601), linopirdine (Sigma L134), retigabine (Alomone D-23129), the cholinomimetic
carbamoylcholine chloride (carbachol; Sigma C4382), muscarine (Sigma M6532), and
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the nicotinic agonist 4-Acetyl-1,1-dimethylpiperazinium iodide (Tocris 0352). Hm1a,
muscarine, and 4-Acetyl-1,1-dimethylpiperazinium iodide were dissolved in deionized
water, aliquoted, and frozen at -20° C. Carbachol was stored as a powder at RT, and
both linopirdine and Retigabine were stored as 100 mM stock solutions in DMSO
(Sigma) aliquoted in -20°C. For pharmacological experiments in which drug was
dissolved in DMSO, the same concentration of DMSO was present in control external
solution. After a baseline recording, drugs were perfused in at 3 mL/min while
continuously recording membrane potential; repeat measurements were performed 10
minutes after wash-in. A subset of cells were recorded for up to 1 hour following washout
of each drug, as needed in some cases to observe complete or near-complete washout.
For experiments using carbachol, repeat measurements were made 5 minutes after
wash-in.
2-P imaging and morphological reconstruction
Where indicated, internal solution contained 0.5% biocytin conjugated to Alexa
Fluor 488, or, in some cases, 50 mM Alexa Fluor alone. After obtaining the whole cell
configuration, the cell was dialyzed for at least 20 minutes; then, the pipette was slowly
removed to allow for the cell to reseal. Two-photon (2P) imaging was performed using a
customized Bruker 2P microscope system with a MaiTai DeepSee Ti:Sapphire pulsed
infrared laser (SpectraPhysics) directed through a modified Olympus BX-61 base
equipped with a GaAsP photodetector (Hamamatsu). 3D image stacks were
reconstructed using the built in ImageJ plugin Simple Neurite Tracer and compressed to
a 2D trace which was analyzed using Matlab. We used “vertical bias” as a summary
statistic to capture the difference between bipolar and multipolar morphologies. We
quantified the total length of dendrite that fell within 30° of vertical (i.e., a line
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perpendicular to the pial surface), and then normalized to the total length of dendrite.
Using this method, bipolar cells had a vertical bias close to 1, while multipolar cells with
processes extending in all directions had vertical bias ranging from near-zero to close to
0.5.
Hodgkin-Huxley VIP-IN model
All simulations were done using custom Matlab code available upon request. We
used classic Hodgkin-Huxley equations with the single addition of a slow K+
conductance, gKS, as in Stiefel et al. (2013). Here, we are using the additional slowly
activating

to model in a generic fashion the effects of M-current mediated irregular

spiking in VIP-INs. The equations for our model are

where V is the membrane voltage, m and h are the activation and inactivation states of
the voltage-gated Na+ conductance, n is the activation variable of the delayed-rectifier K+
conductance, and s is the activation variable of the slow K+ conductance. These
variables are determined by the set of differential equations:
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The equations for h, n, and s all have the same form. For m, the expressions for α and β
are given by

For h, the expressions for α and β are given by

For n, the expressions for α and β are given by

The expressions for s have a fixed

= 300 ms and
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We manually fit the parameters of this model to resemble some of the key
characteristics of VIP-INs, including a high input resistance (small
(small

) and small size

), as well as the approximate I-f curves generated by simulated current

injections (

). The conductances used were
,

,

as described in Figure 8. The reversal potentials were

,
where we varied
= -70,

and

= -70, and

= 50.

Numerical integration was performed using the forward Euler method. We injected
throughout the simulation as a Gaussian white distribution with a max amplitude of 10
pA.
Statistics and experimental design
Data from 62 total mice were used in this study for comparing intrinsic properties
between WT and Scn1a+/- mice. A total of n = 57 VIP-INs from P18-21 and n = 86 VIPINs from P30-55 WT mice, and n = 41 VIP-INs from P18-21 and n = 61 VIP-INs from
P30-55 Scn1a+/- mice were included. We validated our core findings in a subset of
experiments in primary visual cortex, with a total of n = 28 VIP-INs from 4 WT.VIPCre.tdT mice and n = 28 VIP-INs from 6 Scn1a.VIP-Cre.tdT mice age P18-21. All data
were tested for normal distribution by performing a Shapiro-Wilk test and variances were
estimated using Levene’s test. Generally, intrinsic properties from WT and Scn1a VIPINs had equal variances but occasional non-normal distributions. Thus,
electrophysiological data were compared with Mann-Whitney U test for comparisons
between two groups and Kruskal-Wallis test with a post hoc Dunn’s test when comparing
more than two groups. We observed no statistical difference between intrinsic properties
of P18-21 and P30-55 WT VIP-INs and thus did not incorporate a model to account for
changes in development (as in Favero et al., 2018). Therefore, we combined ages for
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most of our analysis. Between 3-10 cells were recorded per mouse. For most
comparisons, each cell as treated as an n, but we confirmed all main findings via
reanalysis with each animal as an n (Figure 3 – Figure suppliment1). For active
properties that involved repeated measures, such as current/frequency plots and spike
rundown with repeated APs, we used a multivariate ANOVA to compare between two
groups, with post hoc Bonferroni correction to estimate p values for each measurement.
For pharmacology experiments, a paired student’s t-test was used to test for the effect of
a drug within a single group. All statistical analysis was performed using custom written
Matlab scripts. Data was visualized using built in Matlab functions, or using the gramm
suite (Morel, 2018).
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SUPPLEMENTAL FIGURES

Figure S1. Scn1a expression in VIP-INs
A) Data from the Allen cell types database, celltypes.brain-map.org/rnaseq which
includes 14,249 cells from the primary visual cortex and 9,573 cells from the anterior
lateral motor cortex (see Methods). Heat map indicating ScnXa RNA transcript levels
in counts per million (CPM) for all GABAergic neurons and excitatory pyramidal cells
in layer 2/3. Each vertical bar represents a single cell. Data was sorted based on
expression of Vip, Sst, and Pvalb (PV). Scn1a is expressed in all GABAergic INs,
including VIP-INs, with highest expression in PV-INs. PV-INs also express Scn8a at
higher levels than Scn2a, while other INs preferentially express Scn2a in addition to
Scn1a. Pyramidal neurons show highest expression of Scn2a and Scn8a, with
relatively limited expression of Scn1a and Scn3a.
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Figure S2. Localization of Nav1.1 on VIP-IN axons.
A) tdT and Nav1.1 signals were measured through a cross sectional line-scan of 30
VIP-IN axons from n = 3 adult WT.VIP-Cre.tdT mice, and divided into positive and
negative axons based on a cutoff of the mean + 2 SD of the Nav1.1 signal level.
Each signal is normalized individually to the max fluorescent intensity within each
line scan. Axons were determined by morphological criteria, having a thin (0.5 μM)
profile and large branching angles.
B) Proportions of VIP-INs that had positive (23/30; 77%) and negative (7/30; 23%)
Nav1.1 expression on an identifiable axon. All “negative” VIP-INs are from the same
field of view as at least one “positive” VIP-IN.
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Figure S3. Validation of Nav1.1 staining.
A) Epifluorescence photomicrographs depicting Nav1.1 immunohistochemistry in a
representative adult WT and P13 Scn1a-/- mouse. Nav1.1 signal is most intense in
layer 4 of the barrel cortex. There is no detectable signal in Scn1a mice using
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identical conditions. Note the apparent difference in Dapi staining is due to the age
difference between WT and Scn1a+/- samples. Scale bar = 100 µM.
B) Confocal microscopy of the same experiment as in A. Nav1.1 signal in layer 2/3 is
more sparse than in layer 4, but many individual processes can be resolved.
Essentially no signal is present in the Scn1a-/- sample. Scale = 50 µM. For A and B,
images are representative of n = 3 mice for each group with at least two technical
replicates for each animal.
C) Nav1.1 immunohistochemistry in a WT.PV-Cre.tdT mouse showing co-labeling of
Nav1.1 on a layer 4 PV-IN axon initial segment, as well as at a distal (presumptively
nodal) portion of a PV-IN axon. Scale = 10 µM.
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Figure S4. IS VIP-IN firing patterns are robust to a variety of stimulation methods
A) Shown is the firing pattern elicited in response to an 8-second square depolarization
from an IS VIP-IN. When the resting membrane potential is depolarized with a DC
offset (to -55 mV), IS VIP-INs show nearly identical firing patterns to that seen in
response to suprathreshold stimulation from rest.
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B) Quantification of firing patterns of n = 16 WT IS VIP-INs from 8 mice shows no
change in either the initial burst length or the ISI CoV in response to prepulse
depolarization.
C) Example traces from a CA VIP-IN and IS VIP-IN in response to either a square 8second current injection or a slow ramp injection with max amplitude of 200 pA. IS
VIP-INs were equally distinguishable using ramp current injections.
D) Quantification of the measured ISI CoV using either a square or ramp current
injection. CA VIP-INs had a smaller ISI CoV (more regular) with ramp currents, while
IS VIP-INs fired with an even more irregular pattern; p-values determined by paired
student’s t-test. n = 33 IS VIP-INs from 13 mice and n = 32 CA VIP-INs from 11 mice.
E) Quantification of the instantaneous firing frequency during ramp current injections to
200 pA calculated with a 20 ms sliding average and aligned to the onset of firing for
each cell (dashed line in C and E). CA VIP-INs show a typical saturating input/output
relationship, while IS VIP-INs show highly non-linear responses, often with initial
bursting. Line and shaded area represent mean ± SEM, and bar indicates
significance at p < 0.001 by a multivariate ANOVA and post hoc Bonferroni test.
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Figure S5. A subset of both CA and IS VIP-INs show bursting at rheobase
A) Examples of CA and IS VIP-INs with and without bursting at rheobase with an intraburst frequency > 100 Hz. Black trace indicates response to a rheobase current
injection, and gray to a 3X rheobase suprathreshold current injection.
B) Relative proportions of CA (18/71) and IS (42/78) VIP-INs in WT.VIP-Cre.tdT mice
that are bursting at rheobase (yellow = bursting, p < 0.001 via chi-square test).
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Table 2 (S1). Properties of VIP-INs from Scn1a+/- and WT littermates
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Figure S6. IS VIP-IN deficits in Scn1a+/- mice are consistent across development.
A) IF curves of CA and IS VIP-INs in the two indicated age ranges. Line and area
represent mean ± SEM, and bar indicates p < 0.01 by a multivariate ANOVA and
post hoc Bonferroni test.
B) Spike amplitude rundown of the same groups in A. Amplitude of repeated action
potentials was measured at 3X rheobase for each cell. Line and area represent
mean ± SEM, and bar indicates p < 0.01 by a multivariate ANOVA and post hoc
Bonferroni test.
C) Individual cells (dots) and population mean ± SEM (error bar); p values determined
by a Kruskal-Wallis with post hoc Dunn’s test; ***, p < 0.001. For A-C, n = 23|42
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(P18|P30) CA and 34|44 (P18|P30) IS cells from 32 WT mice, and n = 17|27
(P18|P30) CA and n = 24|50 (P18|P30) IS cells from 23 Scn1a+/- mice, were
included.

81

Figure S7. IS VIP-IN deficits in Scn1a+/- mice are consistent across cortical areas
A) Heat maps of VIP-IN from primary visual cortex (V1) firing in response to 600 ms test
pulses at 10 pA increments (compare to Figure 3Aiii).
B) IF curves of CA and IS VIP-INs from V1 showing near identical results to barrel
cortex. Line and area represent mean ± SEM, and bar indicates significance at p <
0.05 by a multivariate ANOVA and post hoc Bonferroni test.
C) Individual cells (dots) and population mean ± SEM (error bar); p values determined
by a Kruskal-Wallis with post hoc Dunn’s test.
D) Relative proportions of CA and IS cells in V1 (compare to Figure 2E). A total of n =
13 CA and 15 IS VIP-INs from 4 WT.VIP-Cre.tdT mice and n = 15 CA and 13 IS VIPINs from 6 Scn1a.VIP-Cre.tdT mice were included
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Figure S8. Effects of low concentration Hm1a on IS VIP-IN firing
A) Example traces from recordings of a representative IS VIP-IN from an Scn1a.VIPCre.tdT mouse before and after bath application of 50 nM Hm1a at a 3X rheobase
current injection.
B) Summary data showing an increase in maximal steady-state firing frequency with
application of 50 nM Hm1a. n = 5 VIP-INs from three Scn1a.VIP-Cre.tdT mice; p
values determined by a paired student’s t-test.
C) 8-second ramp depolarization with an amplitude of 200pA of the IS VIP-IN from
panel A. While Hm1a greatly increases firing frequency, IS VIP-INs retain a distinct
irregular spiking firing pattern.
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Figure S9. Kcnq5 is selectively expressed in a subset of VIP-INs
A) Data from the Allen Cell Types Database, celltypes.brain-map.org/rnaseq (as in
Figure S1). Each bar represents RNA-Seq reads in counts per million (CPM)
from a single cell. Kcnq2 is broadly expressed in most GABAergic INs, while
Kcnq5 is generally restricted to VIP-INs, as well as other non-PV/SST INs and
layer 2/3 pyramidal cells. There is very limited expression of Kcnq1,3, and 4 in
any of these populations.
B) As in A, focusing on expression in VIP-INs in layer 2/3 grouped based on
expression of Cck and Calb2 (aka CR). Scn1a is expressed in most VIP-INs with
no preference for Cck or Calb2 expressing VIP-INs. Kcnq5 is also expressed
equally in both Cck and Calb2 containing VIP-INs, although only approximately
50% of both populations express significant levels of Kcnq5. Cells were sorted by
Kcnq5 expression to clearly show the relatively equal proportions of Kcnq5
expression in both Cck and Calb2 populations.
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Figure S10. Kcnq5 but not Kcnq3 is expressed in VIP-INs
A) Confocal micrographs of Kcnq5 staining in layer 2/3 of an adult WT.VIP-Cre.tdT
mouse. Kcnq5 localizes to the soma of many pyramidal neurons as well as a
population (Ci and Cii) of VIP-INs.
B) Same as in A, but in layer 5 of an adult WT.SST-Cre.tdT mouse. Layer 5 pyramidal
neurons, but not SST-INs, stain positive for Kcnq5. Scale = 50 µM for A and B.
C) Enlarged VIP-INs (yellow boxes) from A.
D) Enlarged SST-INs (yellow boxes) from B.
E) Quantification of Kcnq5 staining in VIP and SST-INs. The mean fluorescence of the
Kcnq5 signal in each cell is normalized to the background fluorescence of neuropil.
VIP-INs show a non-normal distribution (p = 1 E -112, one sample KS test) and have
a significantly different distribution than SST-INs (p value indicated, two sample KS
test). n = 293 VIP-INs from 3 WT.VIP-Cre.tdT mice, and n = 117 SST-INs from one
WT.SST-Cre.tdT mouse.
F) Histogram of the distribution of VIP-IN Kcnq5 labelling. The probability density of the
data was fit with a mixture of two normal distributions using maximum likelihood
estimation yielding a mixing parameter of 0.605 with mean and standard deviations
of 1.2 ± 0.2 and 2.3 ± 0.6 (corresponding to 60.5% “negative” and 39.5% “positive”
VIP-INs).
G) Confocal micrographs of Kcnq3 staining in layer 2/3 of an adult WT.VIP-Cre.tdT
mouse. Kcnq3 shows very sparse labelling in cortex, mostly limited to presumptive
ascending apical dendrites, and is not found on VIP-INs. Scale = 50 µM. Images are
representative of n = 3 mice with two technical replicates each.
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Figure S11. Linopirdine has no effect on CA VIP-IN excitability
A) Representative 8-second square depolarization at 2X rheobase of a WT CA VIPIN showing no change in firing pattern.
B) Individual I-f curves for n = 4 cells from 2 WT.VIP-Cre.tdT mice before (gray) and
after (purple) addition of linopirdine.
C) Summary of intrinsic and excitability parameters from the cells in B showing no
change with the addition on linopirdine.
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Figure S12. Muscarinic but not nicotinic receptor activation is sufficient to induce
irregular-tonic switching in IS VIP-INs
A) Example of the response to an 8-second square depolarization of two IS VIP-INs
from adult WT.VIP-Cre.tdT mice before (top) and after (bottom) application of
either 5 µM muscarine or 1 µM of the nicotinic agonist (NIC) 4-Acetyl-1,1dimethylpiperazinium iodide. Scale is 40mV and 1 second.
B) Quantification of changes in firing patters of IS VIP-INs in response to muscarine
(n = 6 cells; 3 mice) or NIC (n = 5 cells; 2 mice). Muscarine caused a switch to a
continuous firing mode represented by increased burst length and decreased ISI
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CoV (indicated by arrowheads as in Figure 6); p-values determined by paired
students’ t-test. There were no apparent changes in IS VIP-IN firing patterns with
NIC application.
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Chapter 3: VIP interneuron dysfunction underlies abnormal
neocortical state transitions and behavior in a severe
neurodevelopmental disorder
ABSTRACT
Dravet Syndrome (DS) is a severe neurodevelopmental disorder caused by loss of
function variants in the gene SCN1A which encodes the voltage-gated sodium (Na+)
channel subunit Nav1.1. Nav1.1-containing Na+ channels support action potential
generation and propagation in GABAergic interneurons (INs), with loss of Nav1.1 leading
to impaired interneuron IN excitability. We recently showed that Vasoactive Intestinal
Peptide interneurons (VIP-INs) express Nav1.1 and are impaired in Scn1a+/- mice. We
hypothesize that VIP-IN mediated disinhibitory circuits are also impaired in Scn1a+/- mice
in vivo, potentially underlying the non-epilepsy features of autism spectrum disorder
(ASD) and intellectual disability (ID) characteristic of DS. To test this, we performed 2photon calcium imaging of genetically identified VIP-INs and excitatory pyramidal
neurons in neocortex in freely behaving Scn1a+/- and WT mice along with pupil diameter
and locomotion speed. We found that VIP-IN mediated cortical state transitions that
accompany behavioral transitions from quiet wakefulness to active running are
suppressed in Scn1a+/- mice. Carbachol exacerbated VIP-IN dysfunction in acute brain
slice from Scn1a+/- mice via downregulation of Na+ current, while optogenetic activation
of VIP-INs during locomotion bouts rescued cortical state transitions in Scn1a+/- mice.
We observed similar cortical dysfunction with VIP-IN selective Scn1a deletion (VIPCre.Scn1a+/fl). VIP-Cre.Scn1a+/fl also recapitulated core behavioral features of the global
DS model, but without seizures or sudden death (SUDEP). Our data indicate that VIP-IN
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mediated circuits are impaired in DS and selectively contribute to the severe ASD and ID
features of DS.
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INTRODUCTION
Interneurons (INs) form a diverse array of microcircuits in the neocortex,
embedded across brain regions based on defined cell types and patterns of connectivity
(Guet-McCreight et al., 2020; Jiang et al., 2015; Kepecs & Fishell, 2014; Pfeffer, 2013;
Yao et al., 2021). These circuits endow the cortex with flexible computational power, yet
also create a vulnerability to neurological disorders caused by disrupted IN function.
Epilepsy and autism spectrum disorder (ASD) are both associated with impaired IN
function (Goff & Goldberg, 2021; Goldberg & Coulter, 2013; Jacob, 2016; Lunden et al.,
2019). However, it is unclear how impairment of specific IN types can lead to both
disorders defined by either state dependent paroxysmal events such as seizures, or as
durable impairments in cognitive function such as ASD and intellectual disability (ID).
Dravet Syndrome (DS) is a severe neurodevelopmental disorder defined by treatmentresistant epilepsy, prominent features of ASD, developmental delay, ID, and sudden
unexplained death (SUDEP). (Dravet, 2011; Dravet & Oguni, 2013). Nearly all cases are
caused by heterozygous loss of function variants in SCN1A encoding the sodium (Na+)
channel  subunit Nav1.1 (Catterall, 2017; Claes et al., 2001; Meisler et al., 2021).
Despite this clearly defined genetic etiology, there are currently no disease modifying
therapies for the associated non-epilepsy comorbidities of ASD and ID (Genton et al.,
2011; Takayama et al., 2014).

At the cellular and circuit level, data from Scn1a+/- mice and neurons generated
from patient derived stem cells demonstrates that Nav1.1 is preferentially expressed in
INs. The three largest classes of cerebral cortical INs, those expressing parvalbumin
(PV), somatostatin (SST), and vasoactive intestinal peptide (VIP-INs) (Rudy et al.,
2011), are hypoexcitable in acute slice preparations from young/developing Scn1a+/100

mice (De Stasi et al., 2016; Favero et al., 2018; Goff & Goldberg, 2019; Tai et al., 2014).
Likewise, knocking out Scn1a in INs but not glutamatergic neurons recapitulates the
global phenotype of seizures and behavioral abnormalities (Oakley et al., 2009; Ogiwara
et al., 2013; Rubinstein et al., 2015; Tatsukawa et al., 2018). Nevertheless, the
hypothesized IN dysfunction is not clearly reflected in vivo in the Scn1a+/- model. PV and
SST-INs fire at similar frequencies in Scn1a+/- mice compared to WT in vivo, and there
are only relatively mild changes in global electrophysiological measures such as EEG
that is not consistent with underlying impairments of IN function. (De Stasi et al., 2016;
Jansen et al., 2021; Tran et al., 2020). Identifying the circuit impact of subtype-specific
interneuron-opathies remains elusive.

There are two contributing factors which may have obscured in vivo studies of
INs in Scn1a+/- mice. The first is that loss of Nav1.1 in PV, SST, and VIP-INs causes
distinct developmental patterns of dysfunction. Specifically, PV-INs show the greatest
impairment near the developmental onset of seizures but regain essentially normal
excitability as Scn1a+/- mice age (Favero et al., 2018; Kaneko et al., 2021). In the
hippocampus, SST-INs show a similar pattern of impairment with the most severe deficit
found around the onset of seizures (~P20) followed by partial stabilization at later time
points(Almog et al., 2021). The second contributing factor is that cellular dysfunction
may be state dependent, which is not well modeled in acute brain slices. For instance,
many ionic conductances including Na+ current respond to changes in neuromodulatory
state producing different firing modes in INs (Cantrell et al., 1996; Cantrell & Catterall,
2001; Goff & Goldberg, 2019; Prönneke et al., 2020). Hence, loss of Nav1.1 may cause
state-dependent IN dysfunction. For instance, Scn1a+/- mice appear to have EEG
abnormalities that depend on their sleep and arousal states (Jansen et al., 2021).
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Recording spontaneous IN activity in anesthetized mice, or even in awake mice without
monitoring activity across changes in cortical states may conceal the impact of IN
dysfunction in Scn1a+/- mice.

VIP-INs are also hypoexcitable in acute brain slices from Scn1a+/- mice, but,
unlike PV-INs, this dysfunction persists through development (Goff & Goldberg, 2019).
VIP-INs selectively target other INs, particularly SST-INs, exerting a primarily
disinhibitory effect on local circuits (Acsády et al., 1996; Fu et al., 2014; A. T. Lee et al.,
2019; S. Lee et al., 2013; Munoz et al., 2017; Pi et al., 2013; Turi et al., 2019).
Depending on the cortical area, VIP-IN disinhibitory microcircuits shape sensory
processing, cortical plasticity, and development, influencing behaviors ranging from
simple stimulus detection to more complex cognitive operations such as memory tasks
and social interaction (Mossner et al., 2020; Newmyer et al., 2019). Therefore, VIP-INs
may be particularly important for the persistent ASD and ID phenotypes of DS. The
disinhibitory role of VIP-INs is reliably linked to cortical state transitions (CSTs) in
sensory and associative cortices which may be critical for stimulus gain control, learning,
and hippocampal and neo-cortical plasticity(Fu et al., 2015; Garcia-Junco-Clemente et
al., 2017; Garrett et al., 2020; Harris & Thiele, 2011; Reimer et al., 2014; Turi et al.,
2019). Such transitions are driven largely by ascending cholinergic neuromodulation,
activating VIP-INs and driving a broad increase in layer 2/3 pyramidal neuron activity
during active behavioral states (McGinley et al., 2015; Reimer et al., 2014). We
hypothesize that the circuit functions of VIP-INs are disrupted in Scn1a+/- mice and may
underlie features of ASD in this model and in human patients.
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Using 2-photon (2P) calcium imaging, we found that VIP-INs were dysfunctional,
and CSTs were impaired in vivo in young adult Scn1a+/- mice. VIP-INs were
unresponsive to cholinergic neuromodulation in vitro as stimulating VIP-INs with
carbachol led to Na+ current down regulation that compounded existing VIP-IN
dysfunction in Scn1a+/- mice. Conversely, boosting VIP-IN function in Scn1a+/- mice using
closed-loop optogenetics rescued network activity during CSTs in vivo. Similar results
were obtained in mice with VIP-IN specific Scn1a deletion (VIP-Cre.Scn1afl/+).
Furthermore, VIP-Cre.Scn1afl/+ mice recapitulated core ASD endophenotypes of the DS
model, yet without epilepsy or SUDEP. Together, these data indicate that loss of Scn1a
in VIP-INs disrupts cortical state dynamics and causes behavioral abnormalities linked to
ASD and ID in DS.
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RESULTS
Abnormal Cortical State Transitions in Scn1a+/- mice

Our previous work demonstrated that VIP-INs are dysfunctional in Scn1a+/- mice
in vitro (Goff & Goldberg, 2019). Importantly, this dysfunction was nearly identical when
recording from either pre-weanling or young adult mice. Based on these results, we
hypothesized that in vivo circuits relying on recruitment of VIP-INs might be impaired in
Scn1a+/- mice. VIP-INs are critical for increased cortical activity in primary sensory areas
during active or aroused behavioral states. These CSTs are largely driven by ascending
cholinergic and noradrenergic inputs, which drive the activity of VIP-INs and promote
disinhibition of superficial cortical layers. Using 2P calcium imaging of GCaMP7s
expressed in VIP-INs and non-VIP cells in primary visual cortex (V1), we recorded
network activity in head-fixed WT and Scn1a+/- mice and compared activity across
behavioral states with simultaneous pupillometry and locomotion tracking (Figure 1A).

VIP-IN activity as well as local network activity was reduced during locomotion
bouts in Scn1a+/- mice compared to age-matched WT littermates (Figure 2 C-E, VIP-INs:
modulation index, MI effect size, -0.11 ± 0.04; p = 0.01. non-VIP neurons: -0.16 ± 0.05; p
= 0.005.). Fewer VIP-INs were positively correlated with pupil diameter (effect size, 0.15; error, 0.07; p = 0.037), and overall network activity was shifted with increased
anticorrelation (+0.16 ± 0.06; p = 0.008) and decreased correlation (-0.19 ± 0.07; p =
0.01) with pupil diameter in Scn1a+/- mice (Figure 2 F). We found that under these
conditions WT and Scn1a+/- mice had a similar number of running bouts, ran at similar
speeds, and had identical degrees of pupil dilation associated with locomotion (Figure
S1). Therefore, blunted CSTs in Scn1a+/- mice are likely independent of differences in
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arousal or behavioral states between genotypes. As an independent readout of network
activity, we examined the background neuropil signal and found a reduced locomotion
MI and reduced correlation with pupil diameter in Scn1a+/- mice (Figure S2).

Figure 1. Altered in vivo VIP-IN activity and CSTs in Scn1a+/- mice. A) Schematic of
experimental design. Adult WT and Scn1a+/- mice implanted with cranial windows over
V1 were head-fixed and allowed to run freely on a floating disk. 2P imagine was
synchronized to locomotion speed and a video feed of the mouse’s pupil and whisker.
Pupil diameter was extracted post-hoc using deeplabcut (DLC). B) 950nm light was used
for simultaneous GCaMP7s imaging and tracking of VIP-IN identity with the red indicator
tdT. Calcium transients, calculated as dF/F0, of non-VIP neurons (tdT-) and VIP-INs
(tdT+) were extracted from each field of view and aligned to behavioral data. Traces of 3
individual non-VIP cells and VIP-INs are shown, along with pupil diameter and running
speed. All traces are z-scored for visual clarity (vertical scale = 4, z-score). C) Heat map
showing calcium transient activity for each cell at the onset of >5s locomotion bouts,
averaged from multiple running bouts and z-scored within each cell. D) Average dF/F0 at
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the onset of locomotion across all VIP-INs and non-VIP neurons (mean and 95% CI).
Black dotted line in C-D represents the onset of locomotion. E) Modulation of dF/F0
during periods of locomotion measured as an index value. F) Histograms of the timezero correlation coefficient between individual cells’ activity and pupil diameter
normalized as a probability density where the area of each bar represents the proportion
of cells that have a value in that bin. Only cells with significant positive or negative
correlation are shown, and the percentages of each are indicated above each histogram.
The percent of positive and negative correlated VIP and non-VIP neurons were
compared across genotype and significant differences are indicated. *, p < 0.05; **, p <
0.01 (see Materials and Methods for information on statistical testing). n = 2511 tdT- and
368 VIP-INs from N = 5 WT mice, n = 4378 tdT- and 577 VIP-INs from N = 6 Scn1a+/mice.
Our method of labelling VIP-INs with tdT is powerful because it allows the
simultaneous imaging of VIP-INs and many hundreds of cells in the local network, but it
does not explicitly distinguish between pyramidal neurons and other non-VIP-INs (both
of which express GCaMP7s but are tdT negative). When we limited our analysis to cells
with very high skew calcium traces, representing almost exclusively pyramidal neurons
(Dipoppa et al., 2018), we found nearly identical results (Figure S3). In fact, an even
larger percentage of Scn1a+/- pyramidal neurons were found to be anticorrelated with
pupil diameter, and on average were negatively modulated by locomotion in Scn1a+/mice. Finally, we measured the correlation between VIP-IN activity and non-VIP INs and
found that during stationary periods, there was decreased correlation between the
activity of VIP-INs and the local network in Scn1a+/- mice (Figure S4). This is despite the
fact that baseline activity levels during stationary behaviors was similar between
genotype based on analysis of the deconvolved event trains of VIP-INs and non-VIP
neurons (Figure S5).

Cholinergic Modulation Exacerbates VIP-IN dysfunction in Scn1a+/- mice

VIP-IN activity is largely driven by ascending cholinergic and noradrenergic
neuromodulation during locomotion and pupil dilation. In addition to direct nicotinic
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Figure 2. Effect of cholinergic modulation on VIP-IN cellular excitability and Na+
current. A-B) Examples of voltage responses of VIP-INs in acute slices of either WT or
Scn1a+/- mice. Cells were stimulated with either A) a square 8s long pulse at 2X
rheobase current or B) a slow 8s ramping current with a max of 200pA. The same cells
are then recorded again after bath application of 5µM Carbachol. C) Current-frequency
relationships for WT and Scn1a+/- VIP-INs elicited from 8s ramping depolarizations. Data
was aligned to the Rheobase current for each cell, and instantaneous firing frequency
was calculated using a 300ms sliding window. Solid lines and shaded areas represent
mean +/- SEM. D) The maximum firing frequency for each WT and Scn1a+/- VIP-IN
during the 8s ramp at baseline and the E) effect of carbachol on the total number of
spikes generated during an 8s ramp depolarization calculated as an index value. F)
Inward Na+ currents recorded in voltage clamp from WT VIP-INs in acute slices from a
single depolarizing step from -80 to 0 mV. Individual sweeps are shown for each
condition. Peak current was measured, repeated during bath application of 5µM
carbachol, and a full or partial washout was observed in the majority of cells. G)
Summary of data from the experiment in F, where connected lines show individual cells
(n = 6 VIP-INs from 5 WT mice). Comparisons and p-values were calculated using a
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paired student’s t-test. There was no difference between Baseline and Washout
conditions. P-values in D-E were determined by the Whitney Mann-U test. Dots
represent individual data points (WT, n = 22 cells; Scn1a+/-, n = 22 cells.
depolarization, we recently showed that carbachol, a stable pan-cholinergic agonist, and
muscarine both enhance WT VIP-IN excitability by modulating firing patterns via
downregulating M-type potassium current. Interestingly, cholinergic second messenger
signaling can also downregulate Na+ current, so we hypothesized that stimulation of VIPINs with carbachol would worsen their function in Scn1a+/- mice. Bath application of 5 µM
carbachol both depolarized and modulated the firing pattern of WT VIP-INs as we
showed previously (Figure 2 A). However, stimulating VIP-INs with slow depolarizing
ramps before and after carbachol application also revealed that the dynamic range of
VIP-INs was shortened as they more readily entered depolarization block (Figure 1 B),
consistent with Na+ channel downregulation. VIP-INs from Scn1a+/- mice, however, fired
at lower frequencies before application of carbachol (42 ± 2.9 vs. 34 ± 2.5 Hz, WT vs.
Scn1a+/-, p = 0.04), and cholinergic modulation caused a massive decrease in their
excitability. In fact, many VIP-INs from Scn1a+/- mice made a near-immediate transition
to depolarization firing only 1-2 APs in response to slow depolarizing ramps (Figure 2 BE, carbachol AP index, -0.21 ± 0.06 vs. -0.63 ± 0.06, WT vs. Scn1a+/-, p = 0.00003). This
was true for all VIP-INs regardless of their initial firing pattern, (i.e. continuous adapting
or irregular spiking; Goff and Goldberg, 2019; Figure S6). In addition, we performed
voltage clamp recordings in VIP-INs from WT mice and found that bath application of
carbachol led to a reversible decrease in Na+ current (Figure 2 F-G). This confirms a
mechanism whereby VIP-IN function is further impaired in Scn1a+/- mice during periods
of high cholinergic tone both in vitro and in vivo through Na+ channel downregulation.
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Figure 3. Optogenetic activation of VIP-INs during locomotion bouts restores
aspects of normal cortical dynamics in Scn1a+/- mice. A) Schematic of experimental
design, as in figure 3A. In addition to recording neural activity, a 1-P laser with a λ =
647nm was directed through the imaging objective for photoactivation of Crimson. B)
Gcamp7s fluorescence was aligned to locomotion data as before, and VIP-INs
expressing ChRimsonR.mCherry were stimulated for 5 s with 20Hz/5ms red light pulses
either every 30 seconds (q30s) or triggered by the onset of locomotion with a 60 second
time-out period in between stimulations (triggered). In this way, we ensured that
stimulation epochs occurred during both locomotion and quiet resting periods for each
mouse. The depicted neural data is an average of all cells within a single FOV. Scale
bar; 0.5 dF/F0, 60 seconds. C) VIP-IN and non-VIP GCaMP7s fluorescent activity elicited
by 5 second laser stimulation during stationary epochs. VIP-INs are uniformly activated
as expected, and non-VIP neurons show a heterogenous response with an average
disinhibitory response across most cells, and strong inhibition of approximately ~10% of
non-VIP cells which are likely the population of INs directly targeted by VIP-INs (p-INs).
Lines and shaded area represent mean ± 95% CI. D) Example df/F0 traces from a single
VIP-IN, p-IN, and non-VIP neuron aligned to a single locomotion bout with and without
concurrent laser stimulation. The lower dotted line represents running speed, the vertical
dotted line is the detected locomotion onset (Lon) and the solid line and shaded area
represents laser stimulation. Scale bar; 1 df/ F0 or 100 mm/s, 2 seconds. E) The
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locomotion modulation index was calculated for each non-VIP neuron separately for
locomotion epochs either with optogenetic VIP-IN activation (Loc + VIPstim) or without
(Loc) compared to quiet wakefulness with no direct VIP-IN activation. 76% of non-VIP
neurons show a greater locomotion modulation index with concurrent VIP-IN activation,
while 78% of p-INs have a lower (more negative) modulation index with concurrent VIPIN activation (inset histogram). F) The average locomotion MI for all non-VIP neurons
and p-IN with or without VIP-IN stimulation. Lines represent the average response of
individual Scn1a+/- mice, and bars represent the grand average of all mice. n = 3,246
non-VIP and 69 VIP cells from n = 5 Scn1a+/- mice. Within group comparisons made with
a paired student’s t-test using the average of each mouse.
Closed loop VIP-IN optogenetic stimulation rescues abnormal network dynamics
in Scn1a+/- mice

The above results suggest that enhancing VIP-IN activity during CSTs could
potentially restore normal network dynamics in Scn1a+/- mice. To test this, we performed
simultaneous 2P imaging with in vivo optogenetic activation of VIP-INs using the red
shifted opsin ChRimsonR (Klapoetke et al., 2014). We found this reliably activated VIPINs during quiescent periods, resulting in local disinhibition of many non-VIP cells
(Figure 3 A-C). There was a small population of cells that were inhibited by VIP-IN
activation which had high baseline activity and low skew calcium traces, likely comprised
of putative INs (p-INs) directly targeted by VIP-INs (Figure S6). Optogenetic
photoactivation of VIP-INs during locomotion bouts in Scn1a+/- mice restored network
activity during CSTs to WT levels (Figure 3 D-F, modulation index, +0.07 ± 0.006; p =
0.001), while the activity of p-INs was dramatically reduced (-0.23 ± 0.04; p = 0.004).
Therefore, direct activation of VIP-INs rescued local cortical circuit function in Scn1a+/mice by enhancing inhibition of inhibitory INs and disinhibiting target principal cells.
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Figure 4. VIP-IN specific loss of Scn1a recapitulates the cellular deficits observed
in VIP-INs in global Scn1a+/- mice A) Voltage response of a WT and VIP-Cre.Scn1a+/fl
VIP-IN to a -50 pA and a 2X rheobase 600ms square current injection. Scale bar = 15
mV and 100 ms. B) Raster plots for all APs elicited from the cells in A in response to
increasing 600ms current injections. The Scn1a+/fl cell enters depolarization block
starting at 100 pA (shown in A), while the WT VIP-IN continues firing past 250 pA. C)
Current frequency relationship for all cells recorded as in A-B. (D) Bar graphs showing
individual cell values (dots) and the population mean ± SEM for the maximal
instantaneous firing frequency of each cell. E) Same for the maximal Steady State firing
frequency (APs during a single 600ms current injection). F – I) Several properties of
single action potentials including F) Action potential voltage threshold G) AP maximum
rise slope H) AP peak voltage and I) amplitude (Peak – threshold). J-K) Other intrinsic
properties of VIP-INs which do not directly reflect function of voltage-gated Na+ channels
are unaffected including J) Resting membrane potential and K) voltage sag in response
to a -50 pA square current injection. n = 30 VIP-INs from 4 VIP-Cre.Scn1a+/fl mice, and n
= 27 VIP-INs from 4 WT mice.
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Conditional deletion of Scn1a in VIP-INs recapitulates physiology and circuit
deficits

In order to better delineate the specific contributions of VIP-INs to DS-related
phenotypes, we crossed Scn1a+/fl mice to VIP-Cre mice to generated VIP-Cre.Scn1a+/fl
mice in which Scn1a loss was genetically limited to VIP-INs. Consistent with the
primarily disinhibitory role of VIP-INs, 0 of 60 of these mice had observable seizures or
sudden unexpected death (SUDEP) prior to experimental end points or sacrificing at
>P150, and 0 of 8 had temperature induced seizures at P21 (up to 42.5º C). We then
confirmed the intrinsic electrophysiological phenotype of VIP-INs is also present in VIPCre.Scn1a+/fl mice as in Scn1a+/- mice. VIP-INs in VIP-Cre.Scn1a+/fl mice showed nearly
identical deficits in AP generation and repetitive firing compared to their WT littermates,
including decreased maximum instantaneous and steady state firing frequencies, as well
as elevated AP threshold, and lower amplitude, peak voltage, and maximum AP rise
slope (Figure 4).

We next measured the in vivo activity of VIP-INs and local non-VIP neurons in
VIP-Cre.Scn1a+/fl mice and WT littermates using 2P calcium imaging. Interestingly, we
found a qualitatively different deficit in VIP-Cre.Scn1a+/fl mice compared to what we
showed for the global Scn1a+/- model. Rather than having decreased modulation at the
onset of locomotion, deconvolved event frequency was decreased at rest in
Scn1a+/fl.VIP-Cre mice (Figure 5 A-C, arbitrary units, -0.03 ± 0.003; p = 0.04).
Unexpectedly, the dynamics of calcium signals from VIP-INs were similar in both
genotypes. We hypothesized that VIP-IN and network activity may remain statedependent under enhanced cholinergic states beyond spontaneous locomotion. To test
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Figure 5. Loss of Scn1a in VIP-INs produces circuit deficits in vivo that are
exacerbated by muscarinic activation. A) Average dF/F0 for all VIP-INs and non-VIP
neurons aligned to the onset of locomotion in WT and Scn1a+/fl mice (as in Figure 1D).
B) Deconvolved event frequency during stationary epochs. C) Locomotion MI as in
Figure 1E. D) Averaged dF/F0 response, as in A, aligned to locomotion bouts after the
injection of 10mg/kg pilocarpine. E) Left: Example of the dF/F0 trace from a single VIP
and non-VIP neuron aligned to a single locomotion bout, below is the same cell after IP
injection of pilocarpine. Right: same but for example cells from and Scn1a+/fl mouse. F)
Locomotion MI of VIP-IN and non-VIP neurons after injection of pilocarpine. G) The
effect of pilocarpine on deconvolved firing frequencies during stationary epochs
calculated as an index value. I) The same as H but for locomotion epochs. For A-C, n =
3343 tdT- and 232 VIP-INs from N = 6 WT mice, n = 3552 tdT- and 316 VIP-INs from N =
7 Scn1a+/fl mice. For D-H, n = 2068 tdT- and 119 VIP-INs from N = 6 WT mice, n = 2384
tdT- and 178 VIP-INs from N = 7 Scn1a+/fl. All cells in D-H were recorded before and
after injection of pilocarpine.
this hypothesis, we injected each mouse for a subset of imaging fields with a low dose of
the muscarinic agonist pilocarpine (10mg/kg) to boost VIP-IN activity, and potentially
recruit the Na+ channel downregulation mechanisms that magnifies the difference
between WT and Scn1a+/- cells (Figure 5 D-F). We compared how pilocarpine modulated
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the activity of individual cells within the same imaging field in both stationary and
locomotion epochs. Overall, pilocarpine caused a rise in the deconvolved event rate of
VIP-INs, with a greater increase in WT VIP-INs compared to those from Scn1a+/fl.VIPCre mice during both stationary (pilocarpine index, -0.1 ± 0.06; p = 0.01) and locomotion
(-0.3 ± 0.1; p = 0.004) epochs. There was also an increase in non-VIP-IN activity that
was greater in WT mice during locomotion epochs (pilocarpine index, -0.15 ± 0.06; p =
0.01). Overall, this locomotion modulation index of VIP and non-VIP neurons increased
in WT mice but decreased it in in Scn1a+/fl.VIP-Cre mice resembling what is found in the
global DS model (Figure 5 G). Therefore, VIP-IN mediated dysfunction persists and is
modulated by cholinergic brain states in Scn1a+/fl.VIP-Cre mice.

Loss of Scn1a in VIP-INs causes ASD and ID endophenotypes

Based on our results from both Scn1a+/- and Scn1a+/fl.VIP-Cre mice, we
hypothesized that cell intrinsic dysfunction of VIP-INs in DS could give rise to
pathological behaviors linked to abnormal disinhibitory circuits. VIP-INs have a relatively
well conserved disinhibitory role across the neocortex and hippocampal formation, and
are important for spatial memory, sociability, and sensory processing. Many of these
behaviors are linked to the pathophysiology of ASD and ID overlap with dysfunctional
behaviors found in Scn1a+/- mice. We tested whether any of the ASD and ID
endophenotypes found in DS models were present in Scn1a+/fl.VIP-Cre mice. We used
paradigms to probe social behavior, spatial memory, anxiety, and repetitive motor
behavior. VIP-Cre.Scn1a+/fl mice interacted less with a novel mouse over a novel object
in a 3 chamber task (social index, -0.14 ± 0.05; p = 0.009), buried more marbles
(+0.16% ± 0.05; p = 0.005), and showed no preference for a novel object at 24h during a
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novel object recognition (NOR) task compared to their WT littermates (object preference
index, -0.16 ± 0.06; p = 0.01). However, there were no differences in open field activity,
or time spent in the open arms of an elevated plus maze (EPM) compared to WT
littermates. Therefore, VIP-Cre.Scn1a+/fl mice show several abnormal behaviors
consistent with the global DS model and conserved among other models of ASD (Han et
al., 2012; Mossner et al., 2020).

Figure 6. Loss of Scn1a in VIP-INs replicates core cognitive impairments and ASD
endophenotypes of the global Scn1a+/- DS model. A) Social interaction index for time
spent with a novel conspecific mouse under a holding cage vs. an identical cage in the
opposite chamber. B) Percent of marbles buried during a 30-minute period in an
individual cage. C) Left: Time exploring a novel object during the first 30 seconds of
exploration. 15 seconds (dotted line) represents equal time spent exploring the novel
and familiar object. *, p < 0.05; **, p < 0.01 for within group comparisons indicating
significantly more time spent with the novel object vs. the familiar object. Right: Total
time spent exploring both the novel and familiar object during a 5-minute test period. D)
Left: total distance travelled during a 15-minute open field period. Center: Running
speed, calculated as the top 10th percentile in speed for each mouse. Right: Percent of
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total time spent in the center of the arena. E) Left: Index of Distance travelled in the open
arm of the elevate plus maze. Right: Index of the total time spent exploring the open
arm. An index of 0 (dotted line) indicates equal time/distance in the open/closed arm. AD) All data are shown as violin plots where the lines represent 5-95% of the population
distribution, the box represents 25-75%, and the middle line is the median value of each
group. Outliers that are > 1.5 the interquartile range are plotted as separate points but
are still included in the analysis. Data from male and female (m/f) mice are plotted
separately, and p-values represent comparisons between genotypes using a mixed
effects model (see materials and methods). N = 26 VIPCre.Scn1afl/+ and n = 23 WT
mice.

DISCUSSION
In this study we explored the known circuit functions of VIP-INs related to a
devastating neurological disorder and investigated the in vivo impact of VIP-IN
dysfunction as it relates to the so-far enigmatic and untreatable ASD and ID
comorbidities of DS. Our main questions were: 1) how does impaired VIP-IN excitability
as observed in Scn1a+/- mice in vitro alter the in vivo disinhibitory circuit function
subserved by this important class of INs, and 2) does cellular and circuit dysfunction of
VIP-INs in vivo translate to abnormal ASD-linked behaviors that define DS. We found
that heterozygous loss of Scn1a produces profound circuit and network level defects in
neocortex which are at least partially caused by VIP-IN intrinsic dysfunction and can be
rescued by enhancing VIP-IN activity during CSTs. Additionally, selective VIP-IN
dysfunction gives rise to features of ASD and ID independent of seizures. Overall, our
work expands our understanding of the role of VIP-INs in the pathogenesis of DS and
more broadly in ASD and ID.

2P imaging in V1 reveals VIP-IN dysfunction and an abnormal disinhibitory
microcircuit in Scn1a+/- mice

We focused on one of the most widely reproduced and well-studied aspects of in
vivo VIP-IN function using 2P calcium imaging to simultaneously assess their activity
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and their impact on the local network. We found that CSTs – which align with active
behavioral states – are impaired in Scn1a+/- mice, with lower VIP-IN and network activity
during active behavioral states. CSTs are largely driven by ascending cholinergic and
noradrenergic tone in sensory cortices, so we also performed simultaneous pupillometry
which accurately tracks this form of neocortical input (Reimer et al., 2014). We found
that the correlation structure of both VIP-INs and local excitatory neurons was degraded
in Scn1a+/- mice, with fewer VIP-INs positively correlated to pupil diameter, decreased
correlation between VIP-IN and network activity, and a shift from a general disinhibitory
response to a push-pull type response in local network activity. Interestingly, network
activity in V1 of Scn1a+/- mice resembles normal dynamics in prefrontal cortex during
similar active behaviors, where SST-INs compete more aggressively with VIP-INs and
cause nearly equal amounts of opposing inhibition (Garcia-Junco-Clemente et al., 2017).
Our general underlying framework is that VIP-INs are now being outcompeted by other
inhibitory INs in V1 in Scn1a+/- mice, consistent with data that shows multiple other IN
types regaining excitability in adult mice (Favero et al., 2018, Almog et al., 2021, Kaneko
et al., 2021). As such, optogenetically stimulating VIP-IN activity during active behaviors
reinstates normal network dynamics by silencing a small population of neurons, likely
representing INs targeted directly by VIP-INs. Overall, this indicates that boosting VIP-IN
function corrects the circuit deficits found in Scn1a+/- mice.

Conditional deletion of Nav 1.1 in VIP-INs also was able to reproduce the intrinsic
electrophysiological phenotype found in Scn1a+/- mice, as well as altered cortical
dynamics consistent with decreased disinhibition. Overall network activity was reduced
in Scn1a+/fl.VIP-Cre mice, however VIP-IN activity as measured by 2P imaging was
similar between WT and Scn1a+/fl.VIP-Cre mice. This indicates that loss of Nav1.1 in
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VIP-INs causes decreased local network activity, although why this is not reflected in
VIP-IN activity is unclear. One explanation is that VIP-IN cellular deficits are too subtle to
reflect in the calcium dynamics recorded at the soma of VIP-INs, but the enhanced
circuit deficit (in both Scn1a+/- and VIP-Cre.Scn1a+/fl mice) is the result of a combination
of both impaired spike generation and propagation (Kaneko et al., 2021). Layered on top
of this is the possibility that other disinhibitory INs in the circuit could be compensating
for decreased VIP-IN function, as compensation in other IN subtypes clearly occurs
(Favero et al., 2018, Almog et al., 2021). Likely candidates are the NDNF expressing
INs, which target PV-INs and are also partially responsible for disinhibition occurring
during locomotion (Cohen-Kashi Malina et al., 2021; Takesian et al., 2018; Tasic et al.,
2016). NDNF-INs likely express Nav1.1 based on single cell RNA-seq data (Tasic et al.,
2016; Yao et al., 2021) which may indicate that these cells are dysfunctional in Scn1a+/mice, but are unimpaired when Nav1.1 deletion is experimentally limited to VIP-INs.

Nevertheless, while baseline in vivo VIP-IN activity was not different in
Scn1a+/fl.VIP-Cre mice, VIP-INs were sensitive to increased cholinergic tone in vivo
similar to our results in acute slices. Low dose pilocarpine greatly boosted the activity of
VIP-INs in WT mice in vivo yet had a markedly reduced effect in Scn1a+/fl.VIP-Cre mice.
In the setting of elevated cholinergic tone, we observed deficits in the modulation of VIPIN and network activity that closely resembled that seen in the global Scn1a+/- mice. We
interpret this data as evidence for context/brain state-dependent VIP-IN dysfunction in
Scn1a+/fl.VIP-Cre mice.

VIP-IN dysfunction underlies ASD and ID endophenotypes but not epilepsy
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Ultimately, Scn1a+/fl mice showed behavioral abnormalities consistent with the
global DS model and other models of ASD yet were seizure free and did not exhibit
premature lethality. Therefore, VIP-INs do not contribute to the seizure phenotype of DS,
but instead give rise to non-seizure features of DS including ASD and ID. The
disinhibitory circuit function of VIP-INs is remarkably conserved in various neocortical
regions as well as the hippocampus and amygdala (Guet-McCreight et al., 2020; Krabbe
et al., 2019; Turi et al., 2019), and VIP-INs are consistently impaired in Scn1a+/- mice
across multiple sensory cortices (Goff & Goldberg, 2019). Recent large scale single cell
RNA sequencing work has demonstrated that IN subtypes, while diverse, tend to show
consistent expression patterns across disparate regions of the neocortex and
hippocampal formation indicating that VIP-IN dysfunction in Scn1a+/- mice could be
widespread (Gouwens et al., 2020; Yao et al., 2021). Future work could help identify
which VIP-IN population(s) in which brain region(s) contribute to the ASD and ID
behavioral abnormalities in DS. For instance, VIP-INs in the hippocampus appear to play
a critical role in the remapping of place cells (Turi et al., 2019), which theoretically could
affect spatial learning tasks in DS mice. Taking a deeper look at V1, VIP-INs also shape
sensory processing in complex ways, boosting gain on small but salient stimuli,
discriminating between novel and familiar images, and coordinating an interaction
between arousal and visual processing (de Vries et al., 2020; Garrett et al., 2020; Khan
et al., 2018; Millman et al., 2020). Future work could also identify the impact of VIP-IN
dysfunction on these important computational processes in DS and other
neurodevelopmental disorders.

While many studies have replicated how various IN subtypes are impaired by
loss of Nav1.1 in vitro, this is the first to show hypofunction of a particular subtype in
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vivo. Our work demonstrates that VIP-IN activity is impaired in a mouse model of DS,
leading to abnormal in vivo disinhibitory microcircuit function and attenuated CSTs. This
is due to intrinsic Na+ channel deficiency and compounded by the effect of ascending
cholinergic modulation of Na+ current density of VIP-INs in Scn1a+/- mice. VIP-IN
dysfunction may be a common locus of cellular dysfunction in models of ASD, and here
may underlie comorbid ASD and ID endophenotypes independent of any direct role in
epilepsy. Indeed, genes implicated in ASD and ID are enriched in VIP-INs, while
transcripts of epilepsy-linked genes are enriched in PV-INs (Goff & Goldberg, 2021).
Therefore, manipulation of VIP-IN activity could represent a therapeutic strategy across
a range of neurodevelopmental disorders. Our data also suggest that that the durable
ASD and ID features of DS, which persist through patients’ lives while seizures tend
improve over time, could potentially be addressed later in life by enhancing VIP-IN
function. Conversely, using seizure control as an output measure may not be the optimal
approach for the development of meaningful therapeutic approaches for DS. VIP-INs
represent a targetable nexus of dysfunction common to a diverse set of neurological
conditions, highlighting the importance of developing new cell type specific tools and
therapies.
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MATERIALS AND METHODS
Table 1. Key Resources
Reagent type
(species) or
resource

Designation

Genetic
reagent (M.
musculis)

Source

Identifiers

Additional
information

129SScn1atm1Kea/Mmjax

Jax

RRID:MM
RRC_037
107-JAX

Dr. Jennifer A.
Kearney,
Northwestern
University

Genetic
reagent (M.
musculis)

Viptm1(cre)Zjh/J

Jax

RRID:IMS
R_JAX:01
0908

Genetic
reagent (M.
musculis)

B6;129P2Pvalbtm1(cre)Arbr/J

Jax

RRID:IMS
R_JAX:00
8069

Genetic
reagent (M.
musculis)

B6J.CgSsttm2.1(cre)Zjh/Mw
arJ

Jax

RRID:IMS
R_JAX:
028864

Genetic
reagent (M.
musculis)

B6.129X1(SJL)Scn1atm2.1Wac/Mm
ucd

UC Davis

RRID:MM
RRC_041
829-UCD

Genetic
reagent (M.
musculis)

129S6.SvEvTac

Taconic

RRID:IMS
R_TAC:
129sve

Genetic
reagent (M.
musculis)

C57BL/6J

Jax

RRID:IMS
R_JAX:00
0664

recombinant
DNA reagent

AAV.CAG.Flex.tdTo
mato

Penn
Vector
Core

AV-9ALL864

recombinant
DNA reagent

AAV.syn.Flex.Gcamp
7s

recombinant
DNA reagent

AAV.syn.Gcamp7s

chemical
compound,

Carbamoylcholine
chloride

2XE+12 GC/mL
7.5XE+12
GC/mL

Sigma

C4382

5 µM
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drug
chemical
compound,
drug

Pilocarpine
hydrochloride

Sigma

software,
algorithm

Pclamp 10

Clampfit

V10.0

software,
algorithm

Matlab

Mathworks

2021a

software,
algorithm

Gramm

10.21105/j
oss.00568

Data
visualization for
Matlab

software,
algorithm

Python

v3.7.1

software,
algorithm

Deeplabcut
(Deeplabcutcore)

Mathis et al
2018

Nvidia
RTX3090
compatible
(added to DLC
> v2.2)

software,
algorithm

Mobile Home Cage

Neurotar

Locomotion
Tracking
Software

software,
algorithm

FlyCapture2

Point Grey
(now FLIR)

SDK for
acquiring video

P6503

0.0b3

10mg/kg IP
injection

Experimental animals

All procedures and experiments were approved by the Institutional Animal Care
and Use Committee at the Children’s Hospital of Philadelphia and were conducted in
accordance with the ethical guidelines of the National Institutes of Health. For 2P
imaging experiments and slice electrophysiology, male and female mice were used in
equal proportions. For mouse behavior experiments, both sexes were used, and sex
was considered in our statistical design (see below); no sex-specific differences were
identified unless otherwise noted, in which case the data was pooled. After weaning at
122

P21, mice were group-housed with up to 5 mice per cage and maintained on a 12-hour
light/dark cycle with ad libitum access to food and water.

Mouse strains used in this study included: Scn1a+/- mice on a 129S6.SvEvTac
background (RRID:MMRRC_037107-JAX) generated by a targeted deletion of exon 1 of
the Scn1a gene, VIP-Cre mice (Viptm1(cre)Zjh/J; RRID:IMSR_JAX:010908 on a mixed
C57BL/6;129S4 background), PV-Cre mice (B6;129P2-Pvalbtm1(cre)Arbr/J;
RRID:IMSR_JAX:008069), SST-Cre mice (B6J.Cg-Ssttm2.1(cre)Zjh/MwarJ;
RRID:IMSR_JAX: 028864), wild-type 129S6.SvEvTac (Taconic Biosciences model
#129SVE; RRID:IMSR_TAC: 129sve), and wild-type C57BL/6J
(RRID:IMSR_JAX:000664). Scn1a+/fl mice (RRID:MMRRC_041829-UCD) were
rederived from frozen embryos in the CHOP mouse genetics core.

Female VIP-Cre homozygous mice were crossed to male 129S6.Scn1a+/- mice to
generate Scn1a.VIP-Cre mice and WT VIP-Cre littermate controls. The genotype of all
mice was determined via PCR of tail snips obtained before P10. All mice used for
experiments were on a near 50:50 129S6:B6J background, and Scn1a+/- mice on this
background have been shown to replicate the core phenotype of Dravet Syndrome
(Miller et al., 2014; Mistry et al., 2014). We previously confirmed that this particular
breeding configuration had similar rates of SUDEP and epilepsy expected (Goff and
Goldberg. 2019). The same approach was used to generate VIP-Cre.Scn1a+/fl mice and
WT VIP-Cre littermate controls, however these mice are on a pure B6J background and
thus WT control groups were not combined. Additionally, both male and female Scn1a+/fl
were used for breeding.

AAV9 injections and Cranial window implantation
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Mice that were used for slice electrophysiology recordings were injected at P0
with AAV9.CAG.Flex.tdTomato as described previously (Gao et al., 2019). Briefly, P0
mice were anesthetized on ice, and then subdurally injected with 1.5 µl of AAV9 split
between both hemispheres. For 2P imaging experiments, VIP-INs from double
transgenic Scn1a.VIP-Cre and WT.VIP-Cre littermates from the cross described above
were labeled via stereotaxic injection of AAV.CAG.Flex.tdTomato. >P35 mice were
anesthetized with isoflurane (induction, 3-4%; maintenance, 1-1.5%) and body
temperature and breathing were continuously monitored. A craniotomy 1 mm anterior
and 3 mm lateral to lambda was made and virus was injected with a 50-75 μm tip
diameter glass pipette driven by a Nanoject III (Drummond Scientific). 60 nL of a mixture
of AAV9.hSyn. GCaMP7s, AAV9.FLEX. GCaMP7s, and AAV9.FLEX.tdT diluted in sterile
PBS was injected at 20 nL/min across 4-5 locations separated by at least 0.5 mm
centered around primary visual cortex V1. The pipette was held in place for 5 min to
allow the virus to spread at each injection location. Following virus injection, a cranial
window made of a 3mm circular coverslip glued to a 5mm circular coverslip was affixed
in place over the craniotomy, and a titanium headbar was cemented on top of the
coverslip. All mice were given Buprenorphine-SR 0.5 mg/kg, cefazolin 500mg/kg, and
dexamethasone 5mg/kg perioperatively and monitored for recovery and infection
periodically for 48 hours following surgery.

Acute slice preparation

Mice were anesthetized with isoflurane and transcardially perfused with ice cold
artificial cerebral spinal fluid (ACSF) containing (in mM): NaCl, 87; sucrose, 75; KCl, 2.5;
CaCl2, 1.0; MgSO4, 6.0; NaHCO3, 26; NaH2PO4, 1.25; glucose, 10, and equilibrated with
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95% O2 and 5% CO2. The brain was removed and mounted on a holder of the Leica VT1200S vibratome and sliced at 300-350 μm thickness. Slices were allowed to recover for
30 minutes in ACSF warmed to 30°C, then maintained at room temperature before
recording. Slices were transferred to a recording chamber on the stage of a BX-61
upright microscope and perfused with recording solution at 30-32° C and 2-3 mL/min
containing, in mM: NaCl, 125; KCl, 2.5; CaCl2, 2.0; MgSO4, 1.0; NaHCO3, 26; NaH2PO4,
1.25; glucose, 25.

Slice recordings

VIP-INs were identified by tdT expression. Whole-cell recordings were obtained
from superficial (layer 2/3) primary somatosensory cortex (S1; “barrel”) and visual cortex
(V1) as described previously. Patch pipettes were pulled from borosilicate glass using a
Narashigi PC-100 puller and filled with intracellular solution containing (in mM): Kgluconate, 130; KCl, 6.3; EGTA, 0.5; MgCl2, 1.0; HEPES, 10; Mg-ATP, 4.0; Na-GTP,
0.3; pH was adjusted to 7.30 with KOH, and osmolarity adjusted to 285 mOsm with 30%
sucrose. Pipettes had a resistance of 4-6 MΩ when filled and placed in recording
solution, with the majority having a resistance of 4.5 – 5 MΩ. Voltage was sampled at 50
kHz with a MultiClamp 700B amplifier (Molecular Devices), filtered at 10 kHz, digitized
using a DigiData 1550A, and acquired using pClamp10 software. Recordings were
discarded if the cell had an unstable resting membrane potential and/or a membrane
potential greater than -50 mV, or if access resistance increased by > 20% during the
recording. We did not correct for liquid junction potential. For experiments using
carbachol, repeat measurements were made 5 minutes after wash-in and up to 30
minutes after wash-out of drug.
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Electrophysiology data analysis

All analysis was performed blind to genotype using custom written Matlab
(Mathworks) code. Resting membrane potential (Vm) was the average value of a 1 s
sweep with no direct current injection. Input resistance (Rm) was calculated using the
responses to -10 to -50 pA hyperpolarizing current injections near rest using Rm = ΔV/I
for each sweep. AP threshold was the value at which the derivative of the voltage (dV/dt)
reached 10 mV/ms. Spike peak refers to the maximum voltage value of an individual AP,
while spike amplitude is the difference between spike height and AP threshold.
Maximum rise slope was taken as the max value of dV/dt during a single AP. Unless
indicated, all quantification of single spike properties was done using the first AP elicited
at rheobase.

Rheobase was determined as the minimum current injection that elicited APs
using a 600 ms sweep at 10 pA intervals. Maximal instantaneous firing was calculated
using the smallest inter-spike interval (ISI) elicited at near-maximal current injection
(before entering depolarization block). Maximal steady-state firing was defined as the
maximum number of spikes generated in a single 600ms sweep, with a minimum
requirement for a spike being an amplitude of 40 mV and height overshooting at least 0
mV. I/f relationships were generated from 600ms current steps as well as from 8 second
ramp depolarizations (Figure 1) as described previously. For Figure 1, the maximum
instantaneous firing rate was calculated from the shortest ISI during a single 8 second
ramp depolarization. The effect of carbachol on firing was calculated as an index value
from the total number of spikes generated before (S0) and after (Scarb) bath application of
carbachol:
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Voltage clamp recordings

Na+ currents were recorded in modified ACSF containing (in mM): NaCl, 125;
KCl, 2.5; CaCl2, 2.0; MgSO4, 1.0; NaHCO3, 26; NaH2PO4, 1.25; glucose, 10; TEA-Cl, 10;
CdCl2, 0.1. Pipettes had a resistance of 3-4 MΩ, and cells which were stable and had an
access resistance < 20 MΩ for 5 minutes after break in were recorded using a series of
100 ms voltage steps from -80 to 50 mV. Peak current was calculated as the max
absolute value of the current response. All values in Figure 1 were calculated using the
peak current elicited at 0 mV.

In vivo 2-P calcium imaging

Imaging was performed using a mode-locked pulsed infrared laser (18-30 mW,
InSight, SpectraPhysics) controlled by a Pockels cell (Conoptics) on a commercial 2P
microscope (Bruker) equipped with a resonant scanner (Cambridge Technology). A
16/0.8 NA water-immersion objective (Nikon) was used. GCaMP7s was imaged at 950
nm with a gallium arsenide phosphide photodetector (H7422-40, Hamamatsu).
Simultaneously, tdT was imaged with a multi-alkali detector (R3896, Hamamatsu). For
experiments using ChRimsonR.mCherry, a single reference image (average of 100
frames) was taken before and after each imaging field at 1020 nm to isolate and verify
mCherry signal. Data were acquired and converted to .tif stacks for analysis.
Fluorescence data was acquired at 30 Hz.
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Approximately 3 weeks after headbar implantation, mice were allowed to
habituate to head fixation in a floating Mobile Home Cage (Neurotar) in the imaging
apparatus for 20-30 minutes daily for 5 days prior to the first imaging experiment. By the
end of habituation, all mice showed spontaneous running bouts, occasional grooming,
and the absence of escape or prolonged freezing behaviors. For test sessions, mice
were allowed to freely ‘move’ in the floating chamber for 12-15 minutes. The chamber
had a transparent siding, and a 7 inch LCD screen (resolution: 1024X600, refresh: 60Hz)
displaying a greyscale image (mean luminance 50 cd/m2) was positioned 15 centimeters
away from and perpendicular to the contralateral eye. Airflow into the Mobile Home
Cage stage provided approximately pink noise during the experiment, measured at ~4045 db. An infrared (IR) ccd camera (Grasshopper 3, Point Grey) was positioned 15
centimeters away from the ipsilateral eye, and the image field was adjusted to include
the entirety of the pupil, whisker pad, and nose, illuminated by a IR light source (850nm).
Pupillometry videos were acquired at 100Hz, and locomotion speed was tracked by the
mobile home cage locomotion tracking software (Neurotar). Neural and behavioral data
acquisition was synced by a TTL pulse at the start and end of each recording session,
and all behavioral data was decimated to match the sample frequency of the
fluorescence data prior to analysis. For in vivo optogenetics experiments, a separate
TTL output from either a master9 (for q30s stimulation, A.M.P.I.) or the mobile home
cage interface (running triggered stimulation) was used to trigger a red laser routed
through the imaging objective (10 mW/mm2, 647 nm OBIS, Coherent). This combination
of stimulation patterns was used to ensure that we collected sufficient epochs where
there was: 1) Laser stimulation during quiescence, 2) Laser stimulation concurrent to
locomotion, and 3) Locomotion epochs without laser stimulation.
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For experiments with pilocarpine, a single FOV was recorded per mouse as
above, then acquisition was stopped, and the mouse was given an intraperitoneal
injection of 10mg/kg pilocarpine. After 10 minutes, the injection was verified by an
increased pupil diameter and increased salivation by the mouse. Imaging and behavioral
data acquisition was restarted after manually adjusting the 2P imaging field to landmarks
such that the same cells were recorded before and after pilocarpine injection.

Cell detection and extraction of neuron activity

The Suite2p package was used for preprocessing of the acquired 2P calcium
imaging data followed by cell detection and extraction of neural activity (Pachitariu et al.,
2017). A non-rigid registration was implemented for the data set in which each image
was divided into sub blocks for more accurate movement correction. Once the images
were registered, alignment metrics were checked for quality of data and few sessions
were excluded if z drift was detected. After registration, cells were detected as ROIs
spatially located around the peaks of the smoothened principal components, and a
blinded experimenter manually rejected non-cell ROIs that were erroneously assigned
as cells. Fluorescence values were extracted from the detected cells and neuropil values
are derived from the area around the cells across the imaging session. In cases where
two imaging sessions on the same field of view were recorded in series (before and after
pilocarpine injection, or using different optogenetic stimulation patters), the resulting
fluorescence data was aligned and combined prior to cell detection in suite2P.

Normalization and background correction
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Because background fluorescence is correlated with locomotion, we adopted the
method of diPoppa et al. (2018) for estimating the adjacent neuropil signal for each cell
and finding the correct scaling factor for background subtracting. Suite2P was used to
output a neuropil mask for each cell extending 30 µm from each ROI, excluding regions
belonging to other detected ROIs. Then, we determined the minimum cellular
fluorescence that corresponded to the surrounding neuropil signal by binning the
neuropil signal Ni(t) into 20 segments and calculating the 5th percentile of the cellular
signal Fi(t) that corresponded to each bin. We then used linear regression to calculate
the correction factor αi for each cell. To avoid overestimating αi with highly active cells
which are strongly correlated to Ni(t), for each FOV we averaged αi from sparsely firing
cells with high skew values (>4) to give a correction value for that experiment αFOV
(Figure S2). For a minority of FOVs that did not have at least 20 high skew cells, we
used an average correction factor from all other FOVs ⟨αFOV⟩ = 0.62.

Analysis of neural activity

Fluorescence values in all figures are reported as

,

where F0, is the 10th percentile of each neuron’s fluorescence trace. F0, was adjusted for
long (>6 minute) recording sessions by using a linear interpolation between the average
F0 values for the first and second half of the recording.

To measure how neural activity is modulated by locomotion, we calculated a
modulation index MI for each cell by separating the entire neural trace into 1 s and
computing the average activity F(t) for each. These chunks were separated based on the
average running speed V(t) > 25mm/s into locomotion (FL) and quiescent (FQ) epochs.
MI was calculated for each cell as
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For Figure 3, MI was calculated independently for FL chunks which also had concurrent
red-light stimulation during at least 15 of 30 sample points within the chunk length.
Chunks with between 1-15 sample points where there was red-light stimulation were
discarded. Using this method, we were able to combine the q30s and triggered data
sets, although our results were nearly identical if we separated our analysis based on
stimulation pattern (not shown).

A Pearson correlation coefficient was used to describe the relationship between
neural activity and pupil diameter

. We then used a shuffle test to determine whether

an individual cell was either positively or negatively correlated with pupil diameter.
Briefly, neural data was divided into 1s chunks and randomly shuffled n = 10000 times,
then

was recalculated for each cell in each shuffle to give a distribution of values

.A

cell was considered to be positively or negatively correlated with pupil diameter if
or

after correcting for multiple comparisons.

For demonstration purposes, we extracted individual running bouts defined by a duration
of running of at least 5s preceded by 10s of quiescence. We then averaged the
trace for each cell across running bouts and plotted the grand averaged and
bootstrapped 95% CI across all cells.
We additionally extracted deconvolved ‘spiking’ event trains
analyses. Briefly, after calculating

for some

for each cell as described above, we used

the OASIS deconvolution algorithm to extract

. In order to tune the values for the
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transient decay constant (tau) and noise floor, we randomly selected a high skew (>2.5)
non-VIP neuron and a moderately high skew (>1) VIP-IN from each FOV and used a
simple threshold to extract a template kernel from each trace. We then fit the decay time
of the kernel as well as the noise floor and averaged across all FOVs used these values
across all experiments.

We then used a previously described de-noising algorithm to remove low
amplitude events that are near the noise floor. Briefly, the maximum of S(t) was scaled
to the maximum of dF(t)/F0 for each cell, and then calculated the median absolute
deviation

of

. We then binned

into 100ms intervals and set the value of

each bin equal to zero if it fell below a multiple of the noise level

where

.

For calculating the modulation index based on ne-noised deconvolved events
S(t) from each cell, we segmented the chunked data in the same way into locomotion
(SL) and stationary (SQ) epochs, and used the simplified formula:

We found that the calculation of locomotion MI using either event traces or
yielded very similar results. We included analyses using event trains primarily
as a tool to describe the baseline activity of neurons independent of locomotion or any
external stimulus, or to compare activity within the same cell across conditions (e.g. +/pilocarpine). However, because the exact relationship between spiking and calcium
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fluorescence likely differs between cell types, we did not attempt to estimate exact firing
rates for any cells or compare firing rates across cell types.

Mouse Behavior

All animal behavior was filmed through a glass bottom chamber (25 x 15 inches)
with opaque sides and lid using a Google Pixel 5 phone camera (1920x1080 30hz). All
mice performed the same panel of behavioral experiments on consecutive days in the
order described below. Mice were maintained on a regular 12h light dark schedule, and
all experiments were performed in a six-hour window around the transition from light to
dark in an isolated dimly lit room. The blinded experimenter exited the room after
initializing all tests. Mice were handled daily for one week prior to performing behavioral
experiments.

Three chamber social task

The test chamber was divided into three equal sections with plexiglass dividers.
A novel C57BL/6 mouse that was age and sex matched to the test animal was placed
under a small square cage that was clear and had gaps large enough for nose-to-nose
interactions. An identical cage was placed in the opposite chamber, and then the test
mouse was placed in the central compartment and allowed to habituate for 5 minutes.
After this time, a portion of the Plexiglas divider was removed exposing a path into each
side chamber, and the test animal was allowed to explore for ten minutes. After this time,
both mice were returned to their home cages, and the apparatus was thoroughly cleaned
with 70% EtOH. Mouse, divider, and holding cage position were extracted from
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behavioral videos using Deeplabcut (DLC, see below) and social preferences were
calculated as index values:

Where
and

denotes the total time the test mouse spent on the side with the novel mouse
on the side with the empty chamber.

Novel object recognition and open field task

Prior to the familiarization phase of the NOR task, mice were allowed to freely
explore and habituate to the empty test chamber for 15 minutes. This open field period
was recorded, and the mouse and chamber positions were extracted using DLC. We
calculated the total distance travelled, average running speed, and percent of time spent
in the center (> 3 inches from the walls). After habituation, the test animal was briefly
removed, and two identical objects were placed diagonally from one another, 3 inches
away from the side wall. The mouse was returned to the chamber and allowed to explore
the objects for 7 minutes. 24 hours later, each mouse was returned to the chamber and
allowed to explore a novel object placed in a new symmetrical location, and a familiar
object used on the day before for a total of 5 minutes. Mouse and object location were
extracted using DLC. However, we found that interaction times based solely on proximity
using these videos were heavily affected by non-exploratory behaviors near each object,
so videos were scored by an independent blind experimenter for time spent interacting
with each object based on previously reported guidelines (Leger et al., 2013) (Figure
S8). The time spent interacting with the novel

and familiar

during the first 30 seconds of total interaction time.

objects was recorded

was compared across groups for
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genotype differences, and we tested the null hypothesis

within each

experimental group with a paired student’s t-test to determine if there was any
preference towards the novel object. Three mice (2 Scn1a+/fl, 1 WT) were excluded for
not spending at least 30 seconds interacting with either object (Leger et al., 2013). Total
time spent exploring both objects was also reported.

Marble Burying

Compulsive and repetitive behaviors were assessed with a marble burying test.
Twelve equally sized marbles were placed in a uniform grid in a standard housing cage
with 2 inches of bedding. A single mouse was allowed to explore the cage for 30
minutes, and following this period of time a single en face photo was taken from 1 ft
away from the surface of the bedding and was scored for % marbles buried by two
blinded experimenters.

Elevated plus maze (EPM)

Two identical EPM apparatus (2ft elevation, arm length of 12 in) with two closed
and two open arms were place in the test room and separated by a white curtain. Videos
were taken from 6 ft above the apparatus, and two mice were tested simultaneously if
they were from the same housing cage. Mice were placed in the center of the apparatus
and allowed to freely explore for 5 minutes. Mouse position and apparatus arm location
were extracted with DLC, and both the time and distance travelled on the open (
)and closed (

and

and

) arm were calculated. Willingness to explore the open arm

was calculated as an index for both time and distance.
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DLC markerless pose estimation

DLC (deeplabcut core development branch v0.0b3, compatible with tensorflow
2.3 and Nvidia ampere architecture) was used on a Windows system equipped with an
Nvidia RTX 3090 GPU. We used separately trained networks for the following
applications: A) Pupil and whisk-ometry during 2P imaging, B) Three chamber social
task, C) Open field and NOR task, and D) EPM task. In all cases, we extracted 5 frames
per animal (10 for pupillometry) using the k-means algorithm and manually labelled the
desired body parts and/or apparatus markers (below). For training, we used the resnet
50 pre-trained model, and otherwise default parameters. We trained each network for
300,000 iterations, and then evaluated the networks for accuracy and generalization,
and in some cases extracted additional outlier frames for labelling and retrained the
network to improve results. Details for the various networks are listed in Table S1.

All marker locations were exported as a csv and analyzed in MATLAB. Where
indicate, ‘mouse position’ refers to an average of the nose, neck, and tail base position.
For pupillometry, the four markers identifying the bounds of the pupil were fit with a
circle, and the diameter was calculated. Saccades, closed eyelids, and grooming were
detected and excluded from analysis. We also extracted a motion index for whisking and
found this to be correlated with pupil diameter as previously reported, but we did not
include this in our analysis of neural activity. All behavioral data extracted from DLC was
filtered with a 300ms rolling average.

Statistical analysis
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Because of the highly nested structure of our data, unless otherwise noted we
primarily relied on linear mixed effects models to determine significant differences
between genotypes. For 2P datasets, where many hundreds of cells are recorded from
each animal, we treated individual mice as random effects and genotype as the fixed
effect. For a given measured parameter (e.g. MI) we constructed models with default
settings in MATLAB using the following formula:

accounting for different baseline values for each mouse (random intercept model). Slope
coefficients and errors (normalized as effect sizes in relation to WT values), and pvalues representing the estimated difference between genotypes are reported in the
main text.

For mouse behavior experiments, we included both male and female mice in our
analysis in accordance with guidance from the NIH. We used mixed effects models to
test for differences between genotypes

and tested whether sex influenced behavior by comparing the above model to a
simplified one:

Sex only had a trend towards an effect on distance travelled in the open arm of the EPM
with males spending less time in the open arm (Effect size: -0.18; Error: 0.06; p-value:
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0.1). For all differences we observed between genotypes, sex did not significantly affect
performance.

In some indicated cases, within group comparisons are made using a paired
student’s t-test. For slice electrophysiology experiments, we treated each cell as n = 1
and made all comparisons using the Kruskal-Wallis test as several parameters did not
have normal distributions. Sample sizes were not estimated with power analyses but
were based on previous studies examining similar phenomenon in models of ASD and
epilepsy. All line and bar graphs show mean +/- bootstrapped 95% CI of the mean
unless noted otherwise. Boxplots show the median, 25/75th and 5/95th percentiles, as
well as statistically determined outliers as indicated.
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SUPPLEMENTAL FIGURES

Figure S1: Markers of behavioral state changes are consistent across genotypes
during 2P imaging sessions. A) Scatter plot of the pupil diameter and running speed
from a single trial from a WT and Scn1a+/- mouse. Each line represents a simple linear fit
of the data. B) Average pupil dilation aligned to the onset of locomotion for all WT and
Scn1a+/- mice. C) the increase in pupil diameter during running bouts calculated as an
index value. D) Average running speed of all WT and Scn1a+/- mice.
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Figure S2: Neuropil background fluorescence correction. A) A scatterplot of a single
non-VIP neuron from a WT mouse with raw cell fluorescence (Fcell) plotted on the y axis,
and the background neuropil fluorescence for that cell (Fneu) at the corresponding time
point. An algorithm to fit the bottom envelope of this plot, corresponding to the lowest
Fcell for any given value of Fneu, was used to calculate the correction factor α (see
Methods). B) The same as in A, but now plotting the corrected cellular fluorescence
signal

on the y axis. C) The same process in A-B was carried out for all

cells in each field of view, including all VIP-INs (gray) and non-VIP neurons (black).
However, to avoid overestimating α for low skew cells, we averaged α for cells with skew
>2.5 and used this value for all cells with skew <2.5. D) Average normalized neuropil
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signal (dFneu/F0neu) as in Figure 1D. E) Locomotion MI of the neuropil signal was reduced
in Scn1a+/- mice. F) Average correlation coefficient with pupil diameter is also reduced. n
= 2511 regions from n = 5 WT mice, n = 4378 regions from n = 6 Scn1a+/-mice.

Figure S3: Isolating definitive pyramidal neurons from tdT- non-VIP neurons. A)
Calcium traces (as shown in Figure 3B) from tdT- non-VIP neurons have a range with
skew values, where high skew cells show sharp transients, and low skew cells have
broader transients. B) Left: Histogram of skew values from 2803 tdt-, 180 PV-Cre.tdT+
and 27 SST-Cre.tdT+ cells (combined, red) from N = 6 WT mice, previously reported
data(Somarowthu et al., 2021). Right: Receiver operating characteristic (ROC) curves
comparing the skew values from tdT- neurons to skew values from PV and SST-INs.
The optimal value for distinguishing tdT- neurons from PV and SST-INs is indicated by
the black X, and when false positives (IN classified as pyramidal neurons) are weighted
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twice as much as false negative, the optimum value is shown by the red X. We used this
more conservative cutoff of 2.43 in our data to isolate a population of non-VIP neurons
that are very likely to be pyramidal neurons (p-Pyr). D) Heatmap of the z-scored dF/ F0
response from each WT and Scn1a+/- p-Pyr aligned to the onset of locomotion. E) The
average locomotion MI for WT and Scn1a+/- mice. F) Histograms of the correlation
coefficient between all p-Pyr and pupil diameter. Only cells that are significantly
correlated with pupil diameter are plotted, and the percent which are either positively or
negatively corelated are indicated above each histogram. n = 1,169 p-Pyr from n = 5 WT
mice, n = 2,334 p-Pyr from n = 6 Scn1a+/- mice.

142

Figure S4: VIP-IN to network correlation is reduced in Scn1a+/- mice. A) Top: Scatter
plot of normalized network (non-VIP neurons) and VIP-IN activity for an example
imaging experiment during stationary epochs. Each dot represents activity during a 1
second interval. Middle: the same for an example Scn1a+/- mouse. Bottom: Average VIP143

IN to network correlation is reduced in Scn1a+/- mice during stationary epochs (Pearson
correlation coefficient, - 0.11 ± 0.04, p = 0.02). B) The same as in A, but during
locomotion bouts. Note the increased VIP-IN and network activity in the WT mouse that
is not present in the Scn1a+/- mouse. Bottom: Scn1a+/- mice trend lower in VIP-IN to
network correlation during locomotion bouts (-0.08 ± 0.05, p = 0.1).

Figure S5: Event deconvolution from dF/F0. A) Example dF/F0 traces from a WT VIPIN and non-VIP neuron, with associated z-scored pupil diameter (blue) and locomotion
(black). B) Calculating the locomotion MI using either dF/F0 or deconvolved event trains
give similar results. Dots represent values for individual cells, and data is fit with a
generalized linear model. Slope + intercept: non-VIP neurons,
, Scn1a+/- vs. WT (p = 0.57, p = 0.72); VIP-INs,

vs.
vs.

,

Scn1a+/- vs. WT (p = 0.33, p = 0.88). C) Estimated event rate during stationary epochs is
not different between genotypes. n = 2511 tdT- and 368 VIP-INs from n = 5 WT mice, n
= 4378 tdT- and 577 VIP-INs from n = 6 Scn1a+/- mice.
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Figure S6: Carbachol has a similar effect on VIP-INs with differing firing patterns.
A) Example continuous adapting (CA) and irregular spiking (IS) VIP-INs in acute slices
from Scn1a+/- and WT adult mice. The voltage response to a 200 pA 8s ramping current
(as in Figure 1) before and after bath application of 5 µm Carbachol is shown for each
cell. B) As in Figure 1 B, the average firing frequency response to 8s ramp
depolarizations for both cell types and both genotypes. C) As in Figure 1 E, the effect of
carbachol on the total number of spikes generated during an 8s ramp calculated as an
index value. Indicated p-values represent differences between genotypes.
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Figure S7: Diverse network responses in response to optogenetically stimulation
of VIP-INs. Heatmap representing z-scored dF/F0 of cells during 2P imaging
experiments aligned to red laser stimulation (described in Figure 3). Top: VIP-INs
expressing ChRimsonR.mCherry are uniformly activated by red light during stationary
epochs Bottom: local non-VIP neuron show diverse responses, with a small disinhibitory
response in the majority of cells, and a strong inhibitory response in 10% of cells that
represent putative inhibitory INs (p-INs ) targeted directly by VIP-INs. Cells are arranged
based on correlation with laser stimulation, and the bottom 10% (large negative), which
approximates the number of non-VIP neurons in layer II/III (Rudy et al., 2011), are taken
to be p-INs.
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Figure S8: Comparison of DLC based proximity scoring and blinded manual
scoring of NOR interactions. A) Correlation of the time spent interacting with the novel
object as an index, either calculated from manually scored videos or based on proximity
from DLC markerless tracking. B) The total time spent exploring either the novel or
familiar object when scored manually vs with DLC. Blinded manual scoring rarely
produces ‘more’ time interacting (above the dotted line) but often produces a lower
amount of total interaction, typically by disregarding grooming or freezing epochs when
the animal is close to each object but not exploring the object.
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Network

Resolution

FPS

Mouse parts labelled

Apparatus labelled

(down

(Hz)

(connected by a skeleton)

30

Nose, neck, tail base, tail

Plexiglass dividers, mouse

tip

cage, empty cage

Nose, neck, tail base, tail

Corners of chamber, 4

tip, paws, ears

demarcated positions 3 inches

sampled)
Three Chamber

Open field/NOR

960x540

960x540

30

from the wall, objects if present
EPM

Pupillometry

1280x720

512x440

30

100

Nose, neck, tail base, tail

Entrance to Open and closed

tip

arms

4 points on pupil (top,

N/A

bottom, left, right), 2 most
posterior whiskers
(insertion and tip)

Table 2 (S1). Data and network training parameters used in DLC pose estimation.
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Chapter 4: Exploring VIP-INs as a therapeutic target in Dravet
Syndrome and Beyond
The data presented so far shows that VIP-INs play a critical role in the underlying
disease pathology of Dravet Syndrome (DS). Like somatostatin (SST) and parvalbumin
(PV-INs), VIP-INs express Nav1.1, and are hypoexcitable in acute brain slices of
Scn1a+/- mice. However, unlike the other IN subtypes studied so far, this dysfunction
persists through development, and is also present when recording VIP-IN activity in vivo
using two-photon (2P) calcium imaging. A widely conserved disinhibitory circuit function
of VIP-INs, regulating cortical state transitions (CSTs) driven by ascending cholinergic
neuromodulation, is diminished in in Scn1a+/- mice and, to a lesser extent, in mice when
Nav1.1 deletion is limited to VIP-INs. Importantly, Nav1.1 deletion in VIP-INs is sufficient
to produce multiple autism spectrum disorder (ASD) related phenotypes that are
consistent with both the global DS model, and another neurodevelopmental disorder
(NDD) model characterized by ASD endophenotypes and shown to involve VIP-IN
dysfunction (Mossner et al., 2020). While the present work is important for
understanding DS at a mechanistic level, it is also critical for understanding the basic
biology of VIP-IN function and to provide a gateway for studying VIP-INs in a broader
context of ASD and intellectual disability (ID). The information summarized above will
hopefully lead to investigation of VIP-IN function in a host of disease models in the
coming years.
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Searching for disease genes important for VIP-IN function
But is it possible to predict which NDDs are more likely to involve VIP-IN
dysfunction? Cutting edge tools and open source big data approaches championed by
the Allen Institute and others may allow us to do just that. Single cell RNA
sequencing (scRNA-seq) provides quantitative gene expression data on thousands of
genes per cell and is scalable up to millions of cells given the appropriate resources. The
Allen Institute has several large scale scRNA-seq data-sets available for public use
(Gouwens et al., 2020; Tasic et al., 2016; Yao et al., 2021), including the most recent set
of data for over 1.1 million neurons from 20 different mouse brain regions using a
combination of Smart-Seq and 10X genomics (Yao et al., 2021). This massive amount of
high dimensional quantitative data is well-positioned for identification of cell types,
particularly when correlated with morphological and electrophysiological data (Gouwens
et al., 2018, 2020; Scala et al., 2020; Yuste et al., 2020). However, such data is also
useful for hypothesis generation when there is limited direct data available for use (Goff
and Goldberg, 2019; Yuste et al., 2020). We analyzed this scRNA-seq dataset (available
at https://portal.brain-map.org/atlases-and-data/rnaseq) to probe the expression of
genes associated with NDDs in VIP-INs.
We selected a group of disease genes used for clinical diagnosis of NDDs that
are found on standard academic and commercially available NextGen sequencing
panels (CHOP Epilepsy Panel v1.0 and a commercial ASD Panel). These two panels
include approximately 250 unique genes (140 on the ASD panel, 76 on the Epilepsy
panel, 25 shared between the two panels) with murine homologues found in the Allen
Brain data. The most common genetic causes of NDDs found in children, including both
Dravet (SCN1A) and Rett syndrome (MECP2), are covered by this selection of genes.
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Table 1. Cell Type Specific Expression of NDD Genes. Values are reported as
trimmed means (25-75%) of log2(CPM). Cell types were assigned based on the
“subclass” labels provided by the Allen Institute. “Glu” includes all glutamatergic cells.
Genes are ordered based on relative expression in VIP-INs and all Glu (*) or all other
INs combined (†) were determined by bootstrapping the difference in means 50,000
times using 10% of each sample population and a Bonferroni-corrected significance
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cutoff. NB, some individual IN subclasses have higher expression of a given gene even
if VIP-INs had higher expression than the combined IN pool. The top genes from each
panel are shown up to and including all significantly different genes.

We first separated the scRNA-seq data based on clustering results from the Allen
Institute (Yao et al., 2021) and focused on gene expression in VIP, SST, and PV-INs
compared to all other INs (which include the Lamp5, Scng, and Meis2 subclasses) as
well as all glutamatergic (Glu) neurons. We then calculated the trimmed mean
expression (25%-75% of Log2(CPM)) of each gene from the above panels and ranked
them based on relative expression in VIP-INs by z-scoring the expression across groups
(Figure 1 A-C). Many genes from both panels were expressed at lower levels in VIP-INs
(Figure 2D) perhaps because, on average, fewer total reads and genes are recovered
from VIP-INs in this dataset compared to other cell types (Yao et al., 2021).This might
particularly affect detection of transcripts with low overall expression levels (see Figure
2D, bottom left quadrant). However, there was a subset of genes that were highly
expressed in VIP-INs when compared with all INs and/or all Glu neurons (Figure 1,
Table 1).
There were several interesting genes that emerged from this analysis that could
aid the investigation into the role of VIP-INs in NDDs as well as inform our understanding
of the biology underlying VIP-IN function. On the ASD Panel, NRXN1 and NRXN3 were
the two most highly expressed genes in VIP-INs, and were both in the top 10 in relative
expression compared to other cell types (Table 1). Neurexins (NRXN1-3) are a family of
synaptic adhesion molecules that are critical for synapse and circuit formation during
development, and are implicated in many neuropsychiatric disorders including ASD (Kim
et al., 2008; Vaags et al., 2012). Their expression is uniquely regulated on a cell type
and regional basis at the transcriptional, translational, and post translational level
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(Fuccillo et al., 2015), yet nothing is known about how they influence VIP-IN mediated
circuits. Mutations in the transcription factor TCF4 cause Pitt-Hopkins syndrome, a
neurodevelopmental disorder defined by ASD with variable but typically severe
developmental delay and ID (Sweatt, 2013). TCF4 itself regulates the expression of both
NRXN1 and CNTNAP2 (Forrest et al., 2012), which are both enriched in VIP-INs, and
pathogenic variants in NRXN1 and CNTNAP2 give rise to a Pitt-Hopkins-like syndromes
(Zweier et al., 2009). However, little is known regarding the cell type-specific activity of
any of these genes.
As an interesting aside, the neurexins, TCF4, and CNTNAP2 are also associated
with neuropsychiatric disorders like schizophrenia through genome wide association
studies (GWAS), as are several other ASD-associated genes expressed in VIP-INs,
including NBEA and CACNA1C (associated with Timothy Syndrome) (Ripke et al.,
2011). CHRNA5A, used in the model of nicotine addiction described above (Koukouli et
al., 2017), is also associated with schizophrenia through GWAS (Schizophrenia Working
Group of the Psychiatric Genomics Consortium, 2014). While beyond the scope of this
discussion, a similar analysis of genes related to various neuropsychiatric disorders
could provide new avenues to study the impact of VIP-INs in this class of pathology.
Many disorders - including Rett syndrome and Dravet syndrome - present with an
overlap of ASD and epilepsy. Angelman Syndrome is caused by functional silencing of
the maternally-imprinted gene UBE3A (through deletion, mutation, or aberrant
methylation) (Mabb et al., 2011). Interestingly, restricting deletion of Ube3a to INs
enhances the abnormal EEG and seizure phenotype found in the global or Glu specific
murine model (Judson et al., 2016), although relatively similar expression across IN
subclasses suggests involvement of multiple cell types (Table 1). Mecp2 is present
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Figure 1. Relative expression of NDD related disease genes in VIP-INs A) Heatmap
showing the expression of genes in a standard NextGen sequencing panel for ASD
calculated as a z-score of the trimmed mean LOG2(CPM) across the 5 indicated cell
types. “Other IN” includes all INs not in the three main subclasses (VIP, SST, and PV).
Genes are sorted based on relative expression in VIP-INs. Below, tan bars on a black
background represent expression of each gene as significantly higher in VIP-INs
compared to either all Glutamatergic cells (*) or all other INs (†, including PV, SST, and
other IN). See Table 1 for raw expression values and statistical test information. B) As in
Figure 1A, but for genes only found on the CHOP Epilepsy v1.0 Panel. C) The same as
Figure 1A-B, but showing genes shared between the two panels. For clarity in Figure
1A-C, genes with no expression in VIP-INs are omitted, including >20 genes with a
mean value of 0 in all cell types, and only the first 50 out of 93 genes from the ASD
panel are shown. D) A scatter plot of the trimmed mean LOG2(CPM) expression of all
241 genes, where VIP-IN expression is on the Y axis and is plotted against the other
indicated cell types on the X axis. Note that equal expression in VIP-INs compared to
another subclass would cause the given data point to fall on the indicated diagonal line.
Most genes, particularly those that are low expressing, are expressed higher in all other
cell types than in VIP-INs. The sparse distribution of points on the top-left of the diagonal
line show genes that are enriched in VIP-INs.
although not enriched in VIP-INs in this scRNA-seq data, but decreased Mecp2 activity
can result in lower levels of Ube3a and Gabrb3 (Samaco et al., 2005), both of which are
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found at higher levels in VIP-INs. As expected, Scn1a is highly expressed in VIP-INs
compared to Glu but is similarly expressed compared to other IN subclasses.
Finally, for the Epilepsy panel genes, there were only two that were enriched in
VIP-INs compared to both Glu and other INs, highlighting our suggestion that VIP-IN
dysfunction may be more closely linked to ASD and ID than epilepsy. Mutations in
ZEB2 cause Mowat-Wilson syndrome which is characterized by moderate to severe
intellectual disability, microcephaly, a high rate of Hirschsprung’s disease, as well as
epilepsy (in 70-75% of cases), but is not a monogenic epilepsy syndrome per se
(Cordelli et al., 2013b, 2013a). While expressed at slightly higher levels in adult VIP-INs,
ZEB2 is also prominently expressed across the brain during early development which is
more likely to account for the many developmental defects seen in this disorder. The
second example, CHRNA4, encodes an  subunit of the nicotinic acetylcholine receptor
that is sparsely expressed in the brain compared to CHRNA2 and 3, similar to CHRNA5
(Dani and Bertrand, 2007). Mutations in CHRNA4 cause a subset of autosomal
dominant nocturnal frontal lobe epilepsy (ADNFLE), a relatively pure epilepsy syndrome
with some motor and cognitive comorbidities (Motamedi and Lesser, 2002). Interestingly,
in two mouse models of ADNFLE expressing human Chrna4a variants, a seizure
phenotype is paradoxically paired with a massive increase in inhibitory post synaptic
current frequency recorded from cortical pyramidal neurons after bath application of
nicotine (Klaassen et al., 2006). Low dose picrotoxin is able to reduce the abnormal EEG
phenotype in these mice, which is counterintuitive and suggests pathologically increased
inhibition. In another study, direct activation of 4-containing nicotinic acetylcholine
receptors also resulted in disinhibition in neocortical layer 5 (Aracri et al., 2017). While
these results are not tied directly to VIP-IN function, they are consistent with the
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hypothesis that Chrna4 may be expressed on VIP-INs (Porter et al., 1999), its loss
resulting in paradoxically increased inhibition in response to nicotinic stimulation. These
studies highlight the complex and varied etiology of seizures and necessitate a better
understanding between cell subclass function and disease endophenotype.
For a given NDD, it is possible that the causative disease gene is expressed
widely across IN or Glu subclasses (as in Ube3a and Mecp2 above). In other disorders,
the causative gene may be preferentially expressed in a specific subclass or subclasses
such that the disease predominantly affects a narrow population of cells. While
expression of the panel genes across cell types was correlated (Figure 2D), the relative
sparsity of genes enriched in VIP-INs suggests that there are at least a handful of
diseases that follow this second pattern. We used dimensionality reduction to visualize
the expression of 241 NDD-associated genes across IN subclasses (Figure 2A).
Surprisingly, the original IN subclasses identified by the Allen Institute were easily
extracted from the TSNE1 and TSNE2 dimensions derived from this limited dataset
using a simple branching classifier, while the same separation was not possible using
random subsets of 250 genes (Figure 2B). Therefore, the information contained within
this selection of NDD-associated transcripts is sufficient to distinguish IN subclasses
from one another. We suggest that differential disease gene expression across IN
subclasses may manifest as distinct disease phenotypes (e.g., epilepsy, features of
ASD, ADHD, etc) associated with each subclass. This highlights the potential of
investigating the role of disease genes using cell type-specific genetic tools.

Points of convergence between experimental models of ASD
A general theme emerging from the scRNA-seq data discussed above is that diseaserelated genes enriched in VIP-INs are more highly associated with ASD/ID relative to
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developmental epilepsy syndromes. Disorders that have prominent features of both
epilepsy and ASD/ID may be the result of mixed dysfunction of multiple cell subclasses.
This is perhaps best exemplified by the fact that lesions of PV-INs (genetic or otherwise)
tend to produce epilepsy in mice (Jiang et al., 2016; Rubinstein et al., 2015), while
lesions restricted to VIP-INs do not produce epilepsy and instead affect attention,
learning, and social behavior (Batista-Brito et al., 2017; Fu et al., 2015; Mossner et al.,
2020). When integrated together in DS, combined PV and VIP-IN dysfunction closely
mirror the development of both epilepsy and ASD. We have discussed the evidence
supporting a role for VIP-INs in the pathogenesis of NDDs with features of ASD;
however, it is useful to consider this within the broader context of pathological
development and function of circuit elements related to ASD, particularly in relation to
the role of disinhibition in dendritic integration. For instance, SCN2A is also an ASDassociated gene expressed in INs but more prominently in glutamatergic neurons (Table
1). Unlike the DS model, Scn2a+/- mice exhibit normal PV and SST-IN excitability, yet
have early impairment in layer 5b principal neuron excitability (P4) and striking
deficiencies in dendritic action potential backpropagation later in development (P27+)
(Spratt et al., 2019). This critically interferes with spike timing dependent plasticity and is
also correlated with more immature dendritic morphology and a disrupted AMPA-NMDA
receptor balance. These results fit well with findings from other ASD models showing
abnormalities in synaptic function, either directly involving synaptic proteins or through
gene transcription (De Rubeis et al., 2014; Sanders, 2015). In addition, dendritic
targeting inhibition provided by SST-INs has precise and compartmentalized control over
dendritic integration (Bloss et al., 2016; Chiu et al., 2013; Murayama et al., 2009).
Upstream from SST-INs, VIP-INs are poised to have a magnified role over post-synaptic
processes like back propagation, spike timing dependent plasticity, and synaptic
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integration including during developmental critical periods (Batista-Brito et al., 2017; Fu
et al., 2015). Thus, VIP-INs may converge on this common conceptual framework for
ASD-associated genes of dysfunctional synaptic plasticity and dendritic integration.
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Figure 2. Separation of IN subclasses based on NDD diagnostic panel genes A)
TSNE plot generated from the first 50 principal components of the 241 unique genes
between the ASD and epilepsy panel using the default settings in MATLAB 2019b.
Individual cells are coloured based on the cell subclasses identified by the Allen Brain
Institute, indicated in the legend. B) The same done for a random selection of 250
genes. The subtypes are more separable when the ASD/Epilepsy panel gene data is
used. C) Receiver operating characteristic (ROC) curves demonstrating the
effectiveness of a binary decision tree classifier fitted to the TSNE1 and TSNE2
dimensions in A and B at recovering the original subclasses labelled by the Allen
Institute. Each ROC curve is created using the posterior probabilities from the trained
decision tree classifier model. For each subclass, the coloured line represents a model
based on the ASD/Epilepsy gene panels, and the grey lines represent 5 different
selections of 250 random genes. The 'X' marks the optimal ROC point for each model. In
all cases, the ASD/Panel genes outperform random selections.

Towards cell type-specific therapies
The evidence we have presented highlights the need to investigate cell-type
specific function and dysfunction in NDDs. But why not instead focus on targeting and
correcting disease-associated genetic lesions at a global level? Part of the answer to this
question lies in the heterogeneity of cell type-specific circuit functions that also change
over the course of development. Taking Dravet syndrome as a case study, SCN1A was
identified as the causative gene twenty years ago (Claes et al., 2001), but the prognosis
for children with Dravet syndrome remains bleak. Seizure control in Dravet Syndrome is
poor, and SUDEP remains a terrifying spectre for parents. However, even in those
patients who attain seizure control, ID and features of ASD remain, and the vast majority
are dependent on others for basic care (Berkvens et al., 2015; Genton et al., 2011;
Takayama et al., 2014). Aspects of this complex pathology may arise from dysfunction of
distinct subclasses of INs that varies over time, suggesting that targeted interventions
given at precise developmental timepoints may be necessary to address the distinct
aspects of the disease.
Identifying a way to selectively target and manipulate INs could provide an
avenue to develop new therapies for Dravet Syndrome. In contrast, global upregulation
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of SCN1A could theoretically be harmful, as patients with gain of function variants of
SCN1A suffer from Familial Hemiplegic Migraine Type 3 (Cestèle et al., 2008; Kahlig et
al., 2008) and rare SCN1A variants identified in an early-onset form of Dravet syndrome
have been shown to act via gain of ion channel function (Berecki et al., 2019; Sadleir et
al., 2017). VIP-INs remain dysfunctional in young adult Scn1a+/- mice, while PV-INs
follow a different developmental trajectory; hence, SCN1A upregulation in discrete IN
subclasses would allow for treatments informed by these developmental trajectories
targeted to IN subclass-specific disease features. A potential solution to achieving this
lies in the SCN1A gene itself. There are different enhancer elements within the SCN1A
locus that drive expression in distinct cell subclasses, including E2 (which drives
expression in PV-INs) and E6 (which is limited to VIP-INs) (Vormstein-Schneider et al.,
2020). Packaging the E2 enhancer element into a virus creates a tool that selectively
drives expression of a desired payload in PV-INs. Moreover, this approach appears to
be equally effective in human neurons from cultured brain slices. Ultimately, cell typespecific technology like this could be paired with a gene therapy tool, such as the
recently developed catalytically dead Cas9 (dCas9) system that is able to boost Nav1.1
expression and enhance the intrinsic excitability of cultured INs when targeted to the
proximal promoter region of the Scn1a locus (Colasante et al., 2019). Hypothetically,
targeting Scn1a-dCas9 or another gene therapy specifically to VIP-INs with the E6
promoter could improve their function without off-target effects and serve as a way to
both investigate and address the underlying VIP-IN mediated component of Dravet
Syndrome pathology. Perhaps, this approach could be broadly adapted as a therapy for
ASD or syndromic NDDs, particularly once we know how mutations in more of the NDD
genes identified above affect VIP-IN function.
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Novel precision therapeutics that lack subclass specific targeting could still be
effective, but ultimately will be limited by the complex and intertwined developmental
trajectories of INs. For instance, a single early (P2) dose of an antisense oligonucleotide
(ASO) targeting the ‘poison exon’ (Carvill et al., 2018) in Scn1a suppresses a
nonproductive alternative splicing event and boosts expression of the remaining copy of
Scn1a, dramatically suppressing seizures and prevented SUDEP in Scn1a+/- mice (Han
et al., 2020). However, the effect of treatment later in development (P14) is reduced, and
treatment after the appearance of spontaneous seizures (P18) – a likely requirement in
human patients – is unknown. Further complicating matters, treatment with an ASO
targeting Scn8a also prevents seizures and SUDEP in Scn1a+/- mice (Lenk et al., 2020),
perhaps indicating that disease symptoms during the chronic phase of Dravet Syndrome
may involve homeostatic or pathological upregulation of Nav1.X channel subunits.
Treatment boosting Scn1a expression in PV-INs later in life, after normalization of
intrinsic excitability, might be less effective at controlling seizures. However, treatment at
a later developmental timepoint might address the durable deficit in VIP-INs while having
limited unintended consequences. As this approach enters human trials (MONARCH
Study; monarchstudy.com), it will be critical to determine whether ASOs are capable of
not only early seizure control, but long-term seizure control and SUDEP risk reduction as
well as an improved neurodevelopmental trajectory without adverse effects.
As we continue to learn more about VIP-INs, accumulating evidence supports the
involvement of VIP-IN dysfunction in the pathogenesis of NDDs like DS. Cutting-edge
approaches in human and mouse genetics, human induced pluripotent stem cell
technology, single cell omics, cell type-specific electrophysiology, opto/chemogenetic
manipulation, and in vivo imaging in model systems will eventually improve our
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understanding of VIP-INs in disease contexts. Ultimately, gene-targeted cell typespecific therapies are on the horizon, informed by continued mechanistic investigation
into the basic biological function of disease genes and the circuit roles of defined classes
of cells including VIP-INs.
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